https://curecurrent.com/trials/a-study-comparing-oxycodone-to-oxycodone-naloxone-in-moderate-to-severe-chronic-cancer-pain-51001https://curecurrent.com/trials/carboplatin-and-etoposide-in-combination-with-vorinostat-for-patients-with-extensive-stage-small-cell-lung-cancer-51002https://curecurrent.com/trials/4-18f-fluoroglutamine-pet-ct-in-imaging-patients-with-newly-diagnosed-lung-cancer-or-indeterminate-pulmonary-nodules-51003https://curecurrent.com/trials/a-phase-i-study-of-belinostat-in-combination-with-cisplatin-and-etoposide-in-adults-with-small-cell-lung-carcinoma-and-o-51004https://curecurrent.com/trials/a-dose-finding-and-expansion-study-of-ro7051790-administered-orally-in-participants-with-relapsed-extensive-stage-diseas-51005https://curecurrent.com/trials/modeling-of-the-response-to-hypofractionated-stereotactic-pulmonary-irradiation-51006https://curecurrent.com/trials/study-of-ly573636-sodium-in-patients-with-metastatic-non-small-cell-lung-cancer-51007https://curecurrent.com/trials/a-study-to-explore-treatment-regimens-and-clinical-outcomes-of-the-nsclc-patients-with-different-dirver-genes-51008https://curecurrent.com/trials/a-randomized-phase-ii-study-of-subatm-itraconazole-in-patients-with-untreated-squamous-nsclc-51009https://curecurrent.com/trials/rh-endostatin-endostar-continuous-intravenous-infusion-51010https://curecurrent.com/trials/sunitinib-non-small-cell-lung-cancer-patients-over-70-51011https://curecurrent.com/trials/early-cancer-detection-test-lung-cancer-scotland-51012https://curecurrent.com/trials/whole-body-electromyostimulation-and-nutritional-therapy-for-patients-with-esophageal-and-bronchial-carcinoma-51013https://curecurrent.com/trials/two-radiation-dose-schedules-of-sbrt-to-lung-metastases-5cm-in-dimension-51014https://curecurrent.com/trials/the-impact-of-trimodal-prehabilitation-strategy-on-patients-undergoing-thoracoscopic-lobectomy-51015https://curecurrent.com/trials/therapeutic-yoga-and-resistance-exercise-for-lung-cancer-51016https://curecurrent.com/trials/a-study-of-val401-in-the-treatment-of-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-51017https://curecurrent.com/trials/a-study-of-sbrt-in-combination-with-rhgm-csf-for-stage-iv-nsclc-patients-who-failed-in-second-line-chemotherapy-51018https://curecurrent.com/trials/a-clinical-trial-to-validate-molecular-targets-of-vorinostat-in-patients-with-aerodigestive-tract-cancer-51019https://curecurrent.com/trials/smoking-cessation-intervention-for-thoracic-patients-51020https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-study-of-abt-751-with-carboplatin-in-patients-with-advanced-lung-cancer-51021https://curecurrent.com/trials/anlotinib-versus-docetaxel-as-the-second-line-treatment-in-egfr-wild-type-patients-with-advanced-nsclc-51022https://curecurrent.com/trials/prognostic-factors-on-malignant-pleural-effusion-51023https://curecurrent.com/trials/powered-vascular-stapler-in-video-assisted-thoracoscopic-vat-lobectomies-51024https://curecurrent.com/trials/safety-and-efficacy-of-buparlisib-bkm120-in-patients-with-untreated-squamous-non-small-cell-lung-cancer-51025https://curecurrent.com/trials/lung-cancer-and-idiopathic-pulmonary-fibrosis-pathological-and-molecular-characterization-51026https://curecurrent.com/trials/virtual-intervention-for-lung-cancer-51027https://curecurrent.com/trials/fdg-pet-ct-scans-in-patients-with-stage-iiib-or-stage-iv-nsclc-undergoing-chemotherapy-51028https://curecurrent.com/trials/extracolonic-findings-on-computed-tomography-ct-colonography-51029https://curecurrent.com/trials/minimum-dose-computed-tomography-of-the-thorax-for-follow-up-in-patients-with-resected-lung-carcinoma-51030https://curecurrent.com/trials/impact-of-perioperative-physical-activity-on-postoperative-pulmonary-complications-and-quality-of-life-among-esophageal-51031https://curecurrent.com/trials/effect-of-chemotherapy-on-pd-l1-in-nsclc-51032https://curecurrent.com/trials/clinical-research-of-s-1-versus-pemetrexed-in-the-maintenance-treatment-of-advanced-nsnsclc-51033https://curecurrent.com/trials/an-investigational-study-of-infliximab-with-prednisone-or-methylprednisolone-versus-prednisone-combination-treatment-in-51034https://curecurrent.com/trials/assessing-the-combination-of-durvalumab-medi4736-and-trabectedin-in-solid-tumors-51035https://curecurrent.com/trials/gold-sodium-thiomalate-in-treating-patients-with-advanced-non-small-cell-lung-cancer-51036https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-stage-ii-iii-non-small-cell-lung-cancer-51037https://curecurrent.com/trials/sc-002-in-small-cell-lung-cancer-and-large-cell-neuroendocrine-carcinoma-51038https://curecurrent.com/trials/3-dimensional-conformal-radiation-therapy-versus-intensity-modulated-radiation-therapy-51039https://curecurrent.com/trials/extensive-staging-in-lung-cancer-51040https://curecurrent.com/trials/venous-thromboembolic-complications-in-ovarian-cancer-51041https://curecurrent.com/trials/pdr001-in-patients-with-non-small-cell-lung-cancer-harboring-kras-nras-mutation-or-no-actionable-genetic-abnormalities-51042https://curecurrent.com/trials/clinical-evaluation-of-the-treatment-of-intellectual-metastases-by-radiosurgery-gamma-knife-by-means-of-a-support-system-51043https://curecurrent.com/trials/capmatinib-in-patients-with-non-small-cell-lung-cancer-harboring-cmet-exon14-skipping-mutation-51044https://curecurrent.com/trials/utb-vbn-ebus-with-or-without-fluoroscopy-for-the-diagnosis-of-ppls-51045https://curecurrent.com/trials/evaluation-of-efficacy-and-toxicity-of-nivolumab-monotherapy-for-advanced-non-small-cell-lung-cancer-after-first-line-tr-51046https://curecurrent.com/trials/a-study-of-axitinib-in-advanced-carcinoid-tumors-51047https://curecurrent.com/trials/phase-1-2-study-of-the-safety-and-efficacy-of-rociletinib-in-combination-with-trametinib-in-patients-with-megfr-positive-51048https://curecurrent.com/trials/clinical-pharmacokinetics-of-tkis-in-chinese-patients-of-hepatitis-b-hbv-51049https://curecurrent.com/trials/ngr-htnf-in-combination-with-standard-chemotherapy-to-treat-patients-with-advanced-non-small-cell-lung-cancer-51050https://curecurrent.com/trials/safety-and-efficacy-of-ttfields-150-khz-concomitant-with-pemetrexed-and-cisplatin-or-carboplatin-in-malignant-pleural-me-51051https://curecurrent.com/trials/study-of-prevalence-of-ipsilateral-shoulder-pain-in-patients-after-thoracic-surgeries-51052https://curecurrent.com/trials/ultrathin-bronchoscope-and-radial-endobronchial-ultrasound-r-ebus-with-fluoroscopy-versus-standard-fiberoptic-bronchosco-51053https://curecurrent.com/trials/rociletinib-co-1686-usa-expanded-access-program-51054https://curecurrent.com/trials/effect-of-chemotherapy-on-tmb-in-nsclc-51055https://curecurrent.com/trials/safety-and-efficacy-study-of-abraxane-in-combination-with-carboplatin-to-treat-advanced-nscl-cancer-in-the-elderly-51056https://curecurrent.com/trials/safety-and-efficacy-clinical-study-of-sns-595-for-second-line-therapy-in-patients-with-advanced-nsclc-51057https://curecurrent.com/trials/a-study-of-rovalpituzumab-tesirine-to-study-cardiac-ventricular-repolarization-in-subjects-with-small-cell-lung-cancer-51058https://curecurrent.com/trials/vistusertib-azd2014-monotherapy-in-relapsed-small-cell-lung-cancer-patients-harboring-rictor-amplification-51059https://curecurrent.com/trials/phase-ii-study-of-azd9291-in-advanced-stage-nsclc-with-egfr-and-t790m-mutations-detected-in-plasma-ct-dna-51060https://curecurrent.com/trials/phase-ii-single-arm-study-of-azd1775-monotherapy-in-relapsed-small-cell-lung-cancer-patients-with-myc-family-amplificati-51061https://curecurrent.com/trials/lung-ultrasound-in-detection-of-extravascular-lung-water-in-septic-patients-51062https://curecurrent.com/trials/extended-low-molecular-weight-heparin-vte-prophylaxis-in-thoracic-surgery-51063https://curecurrent.com/trials/a-study-on-the-correlation-between-tarceva-erlotinib-induced-rash-and-efficacy-in-egfr-mutated-participants-with-advance-51064https://curecurrent.com/trials/non-squamous-nsclc-patients-with-anlotinib-combined-with-pemetrexed-and-cisplatin-51065https://curecurrent.com/trials/concurrent-chemoradiotherapy-combination-with-anlotinib-for-unresectable-stage-iii-nsclc-patients-51066https://curecurrent.com/trials/lung-cancer-early-diagnosis-with-digital-tomosynthesis-re-evaluation-of-lung-nodule-detection-rate-at-5-years-51067https://curecurrent.com/trials/life-lung-bronchoscopy-in-patients-at-risk-for-developing-lung-cancer-51068https://curecurrent.com/trials/a-safety-and-efficacy-trial-of-docetaxel-with-or-without-xh1-in-non-small-cell-lung-cancer-nsclc-patients-51069https://curecurrent.com/trials/ph-1-trial-of-adi-peg-20-plus-docetaxel-in-solid-tumors-with-emphasis-on-prostate-cancer-and-non-small-cell-lung-cancer-51070https://curecurrent.com/trials/open-label-extension-study-with-gefitinib-iressa-for-completing-trial-patients-who-may-benefit-from-further-treatment-51071https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-as-first-line-therapy-in-participants-with-non-small-cell-lung-cancer-harbouring-epidermal-51072https://curecurrent.com/trials/erlotinib-versus-gemcitabine-cisplatin-as-neo-adjuvant-treatment-in-non-small-cell-lung-cancer-51073https://curecurrent.com/trials/video-based-intervention-in-reducing-anxiety-in-patients-undergoing-lung-cancer-screening-51074https://curecurrent.com/trials/itraconazole-in-non-small-cell-lung-cancer-51075https://curecurrent.com/trials/long-term-observation-pms-for-afatinib-51076https://curecurrent.com/trials/sublobar-resection-versus-lobectomy-for-ct1n0m0-non-small-cell-lung-cancer-51077https://curecurrent.com/trials/deferasirox-in-treating-iron-overload-caused-by-blood-transfusions-in-patients-with-hematologic-malignancies-51078https://curecurrent.com/trials/wt1-immunity-via-dna-fusion-gene-vaccination-in-haematological-malignancies-by-intramuscular-injection-followed-by-intra-51079https://curecurrent.com/trials/safety-evaluation-of-panitumumab-and-sirolimus-in-advanced-non-small-cell-lung-cancer-51080https://curecurrent.com/trials/pronostic-and-predictive-value-of-emt-in-localized-lung-cancer-51081https://curecurrent.com/trials/exercise-in-advanced-stage-lung-cancer-patients-51082https://curecurrent.com/trials/neoadjuvant-therapy-combined-with-radical-surgery-for-the-treatment-of-small-cell-lung-cancer-sclc-in-ii-and-iiia-stage-51083https://curecurrent.com/trials/cap7-1-for-the-treatment-of-advanced-stage-therapy-refractory-lung-and-biliary-tract-tumors-51084https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-ovarian-epithelial-cancer-melanoma-acute-myeloid-leukemia-myelodys-51085https://curecurrent.com/trials/endostar-durative-transfusion-combining-with-gemcitabine-cisplatin-to-treat-non-small-cell-lung-cancer-nsclc-51086https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-gefitinib-in-adjuvant-chemotherapy-for-lung-adenocarcinoma-51087https://curecurrent.com/trials/bispectral-index-throughout-esophageal-cancer-operation-51088https://curecurrent.com/trials/anlotinib-plus-docetaxel-for-the-treatment-of-egfr-alk-ros1-mutation-negative-advanced-nonsquamous-nsclc-51089https://curecurrent.com/trials/a-multicenter-open-label-single-arm-multi-cohort-phase-i-study-of-bcd-100-in-patients-with-advanced-solid-tumors-51090https://curecurrent.com/trials/neoadjuvant-finasteride-for-patients-with-non-small-cell-lung-cancer-51091https://curecurrent.com/trials/azd0530-to-treat-recurrent-stage-iiib-iv-nsclc-previously-treated-with-combination-chemotherapy-51092https://curecurrent.com/trials/mesylate-apatinib-combined-with-irinotecan-in-treatment-of-recurrent-small-cell-lung-cancer-51093https://curecurrent.com/trials/intermittent-or-continuous-acetylsalicylic-acid-and-gene-expression-in-the-nasal-tissue-of-current-smokers-51094https://curecurrent.com/trials/feasibility-of-a-web-based-patient-reported-outcome-symptom-monitoring-application-in-danish-lung-cancer-patients-51095https://curecurrent.com/trials/afatinib-and-selumetinib-in-advanced-kras-mutant-and-pik3ca-wildtype-non-small-cell-lung-cancer-51096https://curecurrent.com/trials/ultrasound-guided-central-vein-catheterization-and-complications-51097https://curecurrent.com/trials/photodynamic-therapy-pdt-oncology-registry-51098https://curecurrent.com/trials/sequence-of-vessel-interruption-and-circulating-tumor-cells-in-surgical-lung-cancer-51099https://curecurrent.com/trials/efficacy-and-safety-of-ql1101-and-avastin-respectively-combined-with-paclitaxel-and-carboplatin-in-the-first-line-treatm-51100https://curecurrent.com/trials/epidural-analgesia-and-postoperative-respiratory-functions-epapres-51101https://curecurrent.com/trials/positive-study-part-iii-heidelberg-51102https://curecurrent.com/trials/taxotere-enoxaparin-enoxa-study-51103https://curecurrent.com/trials/study-of-smoking-trajectory-in-newly-diagnosis-lung-cancer-patients-51104https://curecurrent.com/trials/lc-nmr-study-biomarkers-to-detect-lung-cancer-51105https://curecurrent.com/trials/investigation-of-the-contents-and-prognostic-values-of-glucose-metabolism-molecules-in-patients-with-lung-adenocarcinoma-51106https://curecurrent.com/trials/a-study-of-alectinib-ch5424802-ro5424802-in-participants-with-anaplastic-lymphoma-kinase-alk-rearranged-non-small-cell-l-51107https://curecurrent.com/trials/weekly-topotecan-with-docetaxel-in-recurrent-small-cell-lung-cancer-51108https://curecurrent.com/trials/adaptive-radiotherapy-in-non-small-cell-lung-cancer-nsclc-51109https://curecurrent.com/trials/study-of-anlotinib-plus-chemotherapy-as-the-first-line-treatment-in-patients-with-advanced-nsclc-51110https://curecurrent.com/trials/study-for-patients-with-lung-metastatic-advanced-gastric-cancer-and-nsclc-treated-with-apatinib-51111https://curecurrent.com/trials/perioperative-study-of-exercise-training-in-patients-with-operable-cancer-of-the-gastroesophageal-junction-51112https://curecurrent.com/trials/phase-ii-study-of-buparlisib-docetaxel-in-advanced-or-metastatic-squamous-non-small-cell-lung-cancer-nsclc-patients-51113https://curecurrent.com/trials/pulmonary-rehabilitation-for-uncontrolled-asthma-associated-with-elevated-bmi-51114https://curecurrent.com/trials/neoadjuvant-compound-121564-plus-platinum-doublet-chemotherapy-in-non-small-cell-lung-cancer-51115https://curecurrent.com/trials/first-line-combination-treatment-based-on-anlotinib-51116https://curecurrent.com/trials/intervention-to-improve-supportive-care-for-family-caregivers-of-patients-with-lung-cancer-51117https://curecurrent.com/trials/gemcitabine-plus-radiation-therapy-or-combination-chemotherapy-in-treating-patients-with-non-small-cell-lung-cancer-51118https://curecurrent.com/trials/study-of-efficacy-and-safety-of-dabrafenib-and-trametinib-combination-therapy-in-japanese-patients-with-braf-v600e-stage-51119https://curecurrent.com/trials/rovalpituzumab-tesirine-sc16ld6-5-in-recurrent-small-cell-lung-cancer-51120https://curecurrent.com/trials/is-video-assisted-thoracoscopic-lobectomy-a-clinical-alternative-for-surgically-resectable-pathologic-n2-nsclc-patients-51121https://curecurrent.com/trials/neoadjuvant-platinum-based-chemotherapy-for-patients-with-resectable-non-small-cell-lung-cancer-with-switch-to-chemother-51122https://curecurrent.com/trials/a-study-evaluating-dalotuzumab-mk-0646-in-combination-with-erlotinib-for-participants-with-non-small-cell-lung-cancer-mk-51123https://curecurrent.com/trials/atelectasis-formation-using-hfjv-during-stereotactic-solid-organ-ablations-51124https://curecurrent.com/trials/paclitaxel-albumin-stabilized-nanoparticle-formulation-and-sunitinib-as-first-line-therapy-in-treating-patients-with-sta-51125https://curecurrent.com/trials/the-feasibility-and-advantages-of-painless-indwelling-catheter-in-uniportal-vats-lobectomy-of-lung-cancer-51126https://curecurrent.com/trials/recovery-and-rehabilitation-after-lung-cancer-surgery-51127https://curecurrent.com/trials/mobile-lung-nodule-observatory-for-worldwide-evidenced-based-research-51128https://curecurrent.com/trials/telephonic-contact-and-subsequent-physical-follow-up-treated-lung-cancer-patients-51129https://curecurrent.com/trials/clinical-study-of-combined-radical-operation-with-postoperative-adjuvant-chemotherapy-and-prophylactic-cranial-irradiati-51130https://curecurrent.com/trials/atezolizumab-monotherapy-and-consequent-therapy-with-atezolizumab-plus-bevacizumab-for-nsclc-51131https://curecurrent.com/trials/ss1-dsfv-pe38-plus-pemetrexed-and-cisplatin-to-treat-malignant-pleural-mesothelioma-51132https://curecurrent.com/trials/brown-adipose-tissue-activity-and-energy-metabolism-in-cachexia-51133https://curecurrent.com/trials/endostar-combine-with-radiotherapy-in-brain-metastasis-of-nsclc-51134https://curecurrent.com/trials/phase-ii-study-of-therapy-with-ps-341-in-patients-with-advanced-stage-non-small-cell-lung-cancer-51135https://curecurrent.com/trials/enhanced-quitline-intervention-in-smoking-cessation-for-patients-with-non-metastatic-lung-cancer-51136https://curecurrent.com/trials/cpi-613-and-docetaxel-in-treating-patients-with-stage-iiib-or-iv-non-small-cell-lung-cancer-51137https://curecurrent.com/trials/radiation-therapy-with-combination-immunotherapy-for-relapsed-refractory-metastatic-melanoma-51138https://curecurrent.com/trials/thermal-ablation-combined-with-external-beam-radiation-therapy-for-patients-with-inoperable-non-small-cell-lung-cancer-3-51139https://curecurrent.com/trials/s0124-cisplatin-combined-with-irinotecan-or-etoposide-for-extensive-stage-small-cell-lung-cancer-51140https://curecurrent.com/trials/study-to-assess-the-effect-of-azd9291-on-the-blood-levels-of-rosuvastatin-in-patients-with-egfrm-non-small-cell-lung-can-51141https://curecurrent.com/trials/can-recurrence-of-hamartomas-be-prevented-51142https://curecurrent.com/trials/a-study-for-tyrosine-kinase-inhibitors-discontinuation-51143https://curecurrent.com/trials/patient-function-fitness-and-psychosocial-health-in-improving-health-related-quality-of-life-in-patients-with-stage-i-iv-51144https://curecurrent.com/trials/azacitidine-and-entinostat-before-chemotherapy-in-treating-patients-with-advanced-non-small-cell-lung-cancer-51145https://curecurrent.com/trials/phase-i-study-of-the-combination-of-anlotinib-with-gefitinib-51146https://curecurrent.com/trials/intraoperative-ultrasonographic-localization-of-pulmonary-nodules-in-vats-51147https://curecurrent.com/trials/safety-and-efficacy-clinical-study-of-sns-595-in-patients-with-advanced-small-cell-lung-cancer-51148https://curecurrent.com/trials/sunitinib-malate-in-treating-patients-with-small-cell-lung-cancer-51149https://curecurrent.com/trials/a-trial-of-shr-1210-in-combination-with-shr6390-in-patients-with-advanced-crc-nsclc-and-hcc-51150https://curecurrent.com/trials/study-of-oral-cmet-inhibitor-inc280-in-chinese-patients-with-egfr-wild-type-advanced-non-small-cell-lung-cancer-nsclc-51151https://curecurrent.com/trials/study-of-the-application-of-cpap-to-reduce-complications-and-improve-lung-cancer-ablation-radiofrequency-treatment-51152https://curecurrent.com/trials/gemcitabine-hydrochloride-or-pemetrexed-disodium-and-carboplatin-with-or-without-celecoxib-in-treating-patients-with-adv-51153https://curecurrent.com/trials/role-of-pet-scan-in-the-evaluation-of-early-response-to-maintenance-treatment-in-advanced-non-small-cell-lung-cancer-51154https://curecurrent.com/trials/7-hydroxystaurosporine-and-topotecan-hydrochloride-in-treating-patients-with-relapsed-or-progressed-small-cell-lung-canc-51155https://curecurrent.com/trials/optimizing-the-therapeutic-dose-of-apatinib-mesylate-tablets-in-patients-with-lung-cancer-by-dose-titration-a-real-world-51156https://curecurrent.com/trials/genomic-profiling-in-previously-untreated-metastatic-non-small-cell-lung-cancer-51157https://curecurrent.com/trials/anlotinib-plus-chemotherapy-for-patients-with-advanced-non-small-cell-lung-cancer-51158https://curecurrent.com/trials/icotinib-as-consolidation-therapy-after-chemoradiotherapy-in-egfr-mutant-stage-iiia-iiib-non-small-cell-lung-cancer-51159https://curecurrent.com/trials/the-effect-of-lt-to-rt-shunt-using-veno-veno-arterial-extracorporeal-membrane-oxygenation-ecmo-on-coronary-oxygenation-i-51160https://curecurrent.com/trials/an-outcome-analysis-for-stereotactic-body-radiation-therapy-sbrt-treatment-of-non-small-lung-cancer-patients-using-4d-pe-51161https://curecurrent.com/trials/phase-ii-study-for-previously-untreated-subjects-with-non-small-cell-lung-cancer-nsclc-or-small-cell-lung-cancer-sclc-51162https://curecurrent.com/trials/icotinib-as-neoadjuvant-and-adjuvant-therapy-in-egfr-mutant-stage-iiib-or-oligometastasis-non-small-cell-lung-cancer-51163https://curecurrent.com/trials/auy922-in-patient-with-stage-iv-nsclc-51164https://curecurrent.com/trials/locally-invasive-nsclc-treated-with-neo-adjuvant-stereotactic-body-radiotherapy-and-resection-51165https://curecurrent.com/trials/nk-cell-based-immunotherapy-as-maintenance-therapy-for-small-cell-lung-cancer-51166https://curecurrent.com/trials/endostar-in-combination-with-chemoradiotherapy-in-patient-with-advanced-non-small-cell-lung-cancer-51167https://curecurrent.com/trials/icotinib-versus-placebo-as-adjuvant-therapy-in-egfr-mutant-lung-adenocarcinoma-51168https://curecurrent.com/trials/muscle-wasting-in-hemodialysis-patient-51169https://curecurrent.com/trials/bortezomib-and-cisplatin-as-first-line-therapy-in-treating-patients-with-malignant-mesothelioma-51170https://curecurrent.com/trials/pazopanib-hydrochloride-or-a-placebo-in-treating-patients-with-non-small-cell-lung-cancer-who-have-received-first-line-c-51171https://curecurrent.com/trials/comparison-of-22-gauge-and-19-gauge-aspiration-needle-during-ebus-tbna-51172https://curecurrent.com/trials/adaptive-radiotherapy-in-locally-advanced-non-small-cell-lung-cancer-lartia-trial-51173https://curecurrent.com/trials/csmart-liquid-biopsy-and-dynamic-monitor-of-nsclc-patients-in-inner-mongolia-china-51174https://curecurrent.com/trials/bevacizumab-and-erlotinib-in-lung-cancer-with-brain-metastases-a-phase-ii-trial-51175https://curecurrent.com/trials/venous-thromboembolism-in-advanced-lung-cancer-51176https://curecurrent.com/trials/study-of-nintedanib-plus-bevacizumab-in-advanced-solid-tumors-51177https://curecurrent.com/trials/selumetinib-in-combination-with-gefitinib-in-nsclc-patients-51178https://curecurrent.com/trials/a-study-of-ly01008-and-bevacizumab-combined-with-paclitaxel-and-carboplatin-for-treatment-of-na-ve-subjects-with-metasta-51179https://curecurrent.com/trials/tumor-cell-vaccines-and-iscomatrix-with-chemotherapy-after-tumor-removal-51180https://curecurrent.com/trials/photodynamic-therapy-using-porfimer-sodium-in-treating-patients-with-non-small-cell-lung-cancer-and-bronchial-disease-51181https://curecurrent.com/trials/frailty-index-and-geriatric-assessment-in-predicting-toxicity-to-front-line-chemotherapy-in-treating-patients-with-stage-51182https://curecurrent.com/trials/neuroprotective-effects-of-lithium-in-patients-with-small-cell-lung-cancer-undergoing-radiation-therapy-to-the-brain-51183https://curecurrent.com/trials/bioelectrical-impedance-phase-angle-in-predicting-treatment-outcome-in-patients-with-extensive-stage-small-cell-lung-can-51184https://curecurrent.com/trials/adjuvant-oral-decitabine-and-tetrahydrouridine-with-or-without-celecoxib-in-people-undergoing-pulmonary-metastasectomy-51185https://curecurrent.com/trials/effect-of-talactoferrin-in-adults-with-non-small-cell-lung-cancer-51186https://curecurrent.com/trials/evaluation-of-lucanthone-to-whole-brain-radiation-therapy-in-patients-with-brain-metastases-from-non-small-cell-lung-can-51187https://curecurrent.com/trials/18f-flt-imaging-studies-of-treatment-response-for-lung-cancer-and-thymoma-51188https://curecurrent.com/trials/cpi-613-in-treating-patients-with-relapsed-or-refractory-small-cell-lung-cancer-51189https://curecurrent.com/trials/azd2014-and-weekly-paclitaxel-in-squamous-nsclc-51190https://curecurrent.com/trials/quality-of-life-and-survivorship-care-in-patients-undergoing-hyperthermic-intraperitoneal-chemotherapy-hipec-51191https://curecurrent.com/trials/molecular-and-diagnostic-classification-of-non-small-cell-lung-cancer-from-fine-needle-aspirates-51192https://curecurrent.com/trials/mindful-movement-and-breathing-to-improve-outcomes-of-gynecologic-surgery-51193https://curecurrent.com/trials/neratinib-with-and-without-temsirolimus-for-patients-with-her2-activating-mutations-in-non-small-cell-lung-cancer-51194https://curecurrent.com/trials/cryotherapy-in-treating-patients-with-lung-cancer-that-has-spread-to-the-other-lung-or-parts-of-the-body-51195https://curecurrent.com/trials/study-of-nivolumab-plus-chemotherapy-in-patients-with-advanced-cancer-nivoplus-51196https://curecurrent.com/trials/genomic-sequencing-in-determining-treatment-in-patients-with-metastatic-cancer-or-cancer-that-cannot-be-removed-by-surge-51197https://curecurrent.com/trials/carboplatin-plus-etoposide-with-or-without-mpdl3280a-in-untreated-extensive-stage-small-cell-lung-cancer-51198https://curecurrent.com/trials/healthy-directions-after-lung-surgery-pilot-51199https://curecurrent.com/trials/docetaxel-cisplatin-pegfilgrastim-and-erlotinib-hydrochloride-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-51200https://curecurrent.com/trials/methylprednisolone-before-fludeoxyglucose-labeled-positron-emission-tomography-in-patients-with-lung-cancer-51201https://curecurrent.com/trials/effect-of-qigong-on-the-symptom-clusters-of-dyspnea-fatigue-and-anxiety-51202https://curecurrent.com/trials/safety-and-tolerability-study-of-isis-eif4e-rx-in-combination-with-carboplatin-and-paclitaxel-51203https://curecurrent.com/trials/ambulatory-oxygen-in-fibrotic-lung-disease-fld-ambox-51204https://curecurrent.com/trials/the-pittsburgh-vitamin-d-study-vitamin-d-supplementation-in-vitamin-d-deficient-subjects-at-risk-of-lung-cancer-51205https://curecurrent.com/trials/audio-technology-to-detect-lung-cancer-earlier-51206https://curecurrent.com/trials/phase-i-study-of-the-combination-of-anlotinib-with-pemetrexed-or-docetaxel-51207https://curecurrent.com/trials/roniciclib-placebo-in-combination-with-chemotherapy-in-small-cell-lung-cancer-51208https://curecurrent.com/trials/pet-dect-for-staging-and-imaged-based-radiotherapy-planning-in-lung-cancer-51209https://curecurrent.com/trials/effect-of-iloprost-on-pulmonary-oxygenation-in-patients-with-low-diffusing-capacity-during-one-lung-ventilation-51210https://curecurrent.com/trials/azd6244-in-combination-with-docetaxel-versus-docetaxel-alone-in-kras-mutation-positive-nsclc-patients-51211https://curecurrent.com/trials/postoperative-pain-control-with-lipossomic-extended-release-bupivacaine-51212https://curecurrent.com/trials/combination-of-metformin-with-gefitinib-to-treat-nsclc-51213https://curecurrent.com/trials/evaluation-of-a-new-anti-cancer-vaccine-for-patients-with-non-small-cell-lung-cancer-after-tumor-removal-by-surgery-51214https://curecurrent.com/trials/ip3r-modulation-by-cancer-genes-in-mesothelioma-51215https://curecurrent.com/trials/impact-of-aferbio-on-quality-of-life-and-chemotherapy-toxicity-in-lung-cancer-patients-51216https://curecurrent.com/trials/phase-ii-trial-of-carboplatin-and-pemetrexed-ogx-427-in-untreated-stage-iv-non-squamous-non-small-cell-lung-cancer-51217https://curecurrent.com/trials/radiation-therapy-in-preventing-central-nervous-system-cns-metastases-in-patients-with-non-small-cell-lung-cancer-51218https://curecurrent.com/trials/nir-fluorescence-imaging-technique-in-thoracic-surgery-with-icg-51219https://curecurrent.com/trials/pxd101-as-second-line-therapy-in-treating-patients-with-malignant-mesothelioma-of-the-chest-that-cannot-be-removed-by-su-51220https://curecurrent.com/trials/intermittent-and-maintenance-of-icotinib-in-combination-with-pemetrexed-carboplatin-compared-with-icotinib-single-drug-i-51221https://curecurrent.com/trials/paclitaxel-carboplatin-and-bevacizumab-with-or-without-cixutumumab-in-treating-patients-with-stage-iv-or-recurrent-non-s-51222https://curecurrent.com/trials/varenicline-or-nicotine-patch-and-nicotine-gum-in-helping-smokers-in-a-methadone-treatment-program-stop-smoking-51223https://curecurrent.com/trials/a-phase-1-2a-study-of-abt-263-in-subjects-with-small-cell-lung-cancer-sclc-or-other-non-hematological-malignancies-51224https://curecurrent.com/trials/comparison-of-veliparib-and-whole-brain-radiation-therapy-wbrt-versus-placebo-and-wbrt-in-adults-with-brain-metastases-f-51225https://curecurrent.com/trials/calcitriol-in-preventing-lung-cancer-in-smokers-and-former-smokers-at-high-risk-of-lung-cancer-51226https://curecurrent.com/trials/predicting-tolerance-to-radiation-therapy-in-older-adults-with-cancer-51227https://curecurrent.com/trials/a-study-of-imc-a12-cixutumumab-with-and-without-other-standard-chemotherapies-in-participants-with-lung-cancer-who-have-51228https://curecurrent.com/trials/dabrafenib-and-trametinib-in-patients-with-non-small-cell-lung-cancer-harboring-v600e-braf-mutation-51229https://curecurrent.com/trials/combined-diagnosis-of-ct-and-exosome-in-early-lung-cancer-51230https://curecurrent.com/trials/personalized-dc-vaccine-for-lung-cancer-51231https://curecurrent.com/trials/study-of-vandetanib-combined-with-chemotherapy-to-treat-advanced-non-small-cell-lung-cancer-51232https://curecurrent.com/trials/phase-i-hypofractionated-stereotactic-boost-radiotherapy-for-non-small-cell-lung-cancer-51233https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-inhaled-laninamivir-octanoate-twincaps-dpi-in-adults-with-chronic-asthma-51234https://curecurrent.com/trials/anti-ctla-4-antibody-followed-by-anti-pd-1-antibody-in-recurrent-or-metastatic-nsclc-51235https://curecurrent.com/trials/right-ventricular-inflammation-after-lung-resection-51236https://curecurrent.com/trials/feasibility-study-of-tumor-blood-flow-measurement-by-detection-of-positron-activation-post-proton-therapy-ds01-51237https://curecurrent.com/trials/molecular-signatures-of-relapse-in-tissue-samples-from-patients-with-small-cell-lung-cancer-who-are-receiving-cisplatin-51238https://curecurrent.com/trials/poziotinib-in-stage-iv-lung-adenocarcinoma-with-her2-mutation-kastt001-51239https://curecurrent.com/trials/feasibility-study-of-navigated-endoscopy-for-the-placement-of-high-dose-rate-brachytherapy-applicators-in-the-esophagus-51240https://curecurrent.com/trials/the-jules-bordet-institute-molecular-profiling-program-feasibility-trial-51241https://curecurrent.com/trials/irinotecan-for-previously-treated-advanced-non-small-cell-lung-cancer-51242https://curecurrent.com/trials/local-therapies-for-oligometastatic-non-small-cell-lung-cancer-harboring-sensitizing-egfr-mutations-51243https://curecurrent.com/trials/a-study-to-explore-clinical-characteristics-and-prognoses-of-n2-patients-with-non-small-cell-lung-cancer-51244https://curecurrent.com/trials/a-study-to-evaluate-effectiveness-and-safety-of-surgeries-in-elderly-nsclc-patients-51245https://curecurrent.com/trials/circulating-tumor-dna-detection-in-surveillance-of-surgical-lung-cancer-patients-51246https://curecurrent.com/trials/a-study-to-evaluate-clinical-characteristics-of-lung-cancer-in-patients-with-surgeries-and-adjuvant-therapies-51247https://curecurrent.com/trials/a-study-to-evaluate-effectiveness-of-sublobar-dissection-in-patients-with-non-small-cell-lung-cancer-51248https://curecurrent.com/trials/an-observational-study-to-explore-clinical-characteristics-of-the-patients-with-t1-non-small-cell-lung-cancer-51249https://curecurrent.com/trials/a-study-to-explore-prognoses-of-the-patients-with-n2-non-small-cell-lung-cancer-51250https://curecurrent.com/trials/meditation-based-breathing-training-in-improving-target-motion-management-and-reducing-distress-in-patients-with-abdomin-51251https://curecurrent.com/trials/a-study-in-non-small-cell-lung-cancer-51252https://curecurrent.com/trials/topotecan-and-vinorelbine-in-treating-patients-with-recurrent-lung-cancer-51253https://curecurrent.com/trials/study-to-assess-safety-and-tolerability-of-mln8237-in-combination-with-erlotinib-to-treat-non-small-cell-lung-cancer-51254https://curecurrent.com/trials/anti-muc1-car-t-cells-and-pd-1-knockout-engineered-t-cells-for-nsclc-51255https://curecurrent.com/trials/surgical-versus-non-surgical-staging-of-lung-cancer-51256https://curecurrent.com/trials/study-of-px-866-and-docetaxel-in-solid-tumors-51257https://curecurrent.com/trials/pilot-study-of-novel-fluorescence-endoscopic-device-for-sentinel-lymph-node-mapping-in-lung-cancer-51258https://curecurrent.com/trials/home-respiratory-rehabilitation-in-advanced-lung-cancer-chemotherapy-per-os-51259https://curecurrent.com/trials/a-phase-ib-trial-of-a-maintenance-multipeptide-vaccine-s-588210-in-patients-with-unresectable-malignant-pleural-mesothel-51260https://curecurrent.com/trials/thin-ebus-in-ex-vivo-human-lungs-51261https://curecurrent.com/trials/an-observational-study-of-avastin-bevacizumab-in-elderly-patients-with-non-squamous-non-small-cell-lung-cancer-in-clinic-51262https://curecurrent.com/trials/ebus-tbna-vs-flex-19g-ebus-tbna-51263https://curecurrent.com/trials/stereotactic-radiosurgery-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-cancer-51264https://curecurrent.com/trials/retrospective-comparative-study-of-routine-lower-neck-ct-in-the-staging-and-diagnosis-of-lung-cancer-across-two-cohorts-51265https://curecurrent.com/trials/nk-cell-activity-in-smokers-screened-for-lung-cancer-51266https://curecurrent.com/trials/study-of-autologous-immune-killer-cells-in-patients-with-late-stage-hepatocellular-carcinoma-or-lung-cancer-51267https://curecurrent.com/trials/lung-stereotactic-body-radiotherapy-sbrt-delivered-over-4-days-versus-11-days-51268https://curecurrent.com/trials/mechanisms-of-immunosurveillance-for-lung-cancer-51269https://curecurrent.com/trials/the-emprint-ablate-and-resect-study-in-patients-with-metastatic-lung-tumors-empress-51270https://curecurrent.com/trials/spectrum-analysis-in-ex-vivo-human-lungs-51271https://curecurrent.com/trials/metformin-and-carbohydrate-restriction-with-platinum-based-chemotherapy-in-stage-iiib-iv-non-squamous-non-small-cell-lun-51272https://curecurrent.com/trials/concomitant-radio-chemotherapy-in-the-elderly-51273https://curecurrent.com/trials/thin-prep-versus-traditional-cytological-procedure-for-lung-cancer-51274https://curecurrent.com/trials/prognostic-evaluation-of-tumor-volume-and-its-changes-in-radical-radiotherapy-of-advanced-nsclc-51275https://curecurrent.com/trials/study-of-s-3304-in-patients-with-locally-advanced-non-small-cell-lung-cancer-51276https://curecurrent.com/trials/assessment-of-high-flow-nasal-cannula-oxygenation-in-ebus-bronchoscopy-51277https://curecurrent.com/trials/a-mobile-supportive-care-app-for-patients-with-metastatic-lung-cancer-51278https://curecurrent.com/trials/an-immuno-therapy-study-of-experimental-medication-bms-986205-given-with-nivolumab-with-or-without-chemotherapy-compared-51279https://curecurrent.com/trials/nivolumab-in-treating-patients-with-stage-iv-or-recurrent-lung-cancer-with-high-mutation-loads-51280https://curecurrent.com/trials/an-open-label-phase-i-ii-clinical-study-of-pt-112-in-combination-with-docetaxel-in-subjects-with-advanced-solid-tumor-in-51281https://curecurrent.com/trials/phase-ii-trial-to-evaluate-the-efficacy-and-safety-of-hm61713-as-the-1st-line-nsclc-anticancer-therapy-51282https://curecurrent.com/trials/phase-i-ii-trial-to-evaluate-safety-tolerability-and-pharmacokinetic-profile-of-hm61713-in-nsclc-patients-51283https://curecurrent.com/trials/comparison-of-imatinib-versus-dasatinib-in-patients-with-newly-diagnosed-chronic-phase-chronic-myeloid-leukaemia-51284https://curecurrent.com/trials/pilot-trial-of-egf-ointment-for-the-patients-with-egfr-i-related-skin-side-effects-51285https://curecurrent.com/trials/a-phase-i-ii-study-of-ganetespib-in-combination-with-doxorubicin-51286https://curecurrent.com/trials/broncho-adventitial-delivery-of-paclitaxel-to-extend-airway-patency-in-malignant-airway-obstruction-patients-51287https://curecurrent.com/trials/safety-and-efficacy-of-oshadi-d-and-oshadi-r-for-malignant-mesothelioma-treatment-51288https://curecurrent.com/trials/oshadi-d-and-oshadi-r-in-combination-with-docetaxel-as-2nd-line-therapy-for-metastatic-non-small-cell-lung-cancer-51289https://curecurrent.com/trials/a-safety-study-of-nivolumab-in-combination-with-ipilimumab-in-participants-with-advanced-non-small-cell-lung-cancer-51290https://curecurrent.com/trials/azacitidine-and-cisplatin-in-patients-with-advanced-lung-or-head-and-neck-cancer-51291https://curecurrent.com/trials/epidemiology-and-psychosocial-evaluation-of-inpatient-with-lung-opacity-51292https://curecurrent.com/trials/pulmonary-interstitial-lymphography-in-early-stage-lung-cancer-51293https://curecurrent.com/trials/perspectives-of-receiving-open-versus-minimally-invasive-surgery-51294https://curecurrent.com/trials/azd2171-and-pemetrexed-disodium-in-treating-patients-with-relapsed-non-small-cell-lung-cancer-51295https://curecurrent.com/trials/study-evaluating-the-safety-of-hki-272-neratinib-in-subjects-with-advanced-non-small-cell-lung-cancer-51296https://curecurrent.com/trials/salivary-biomarkers-for-non-small-cell-lung-cancer-detection-51297https://curecurrent.com/trials/postoperative-pain-after-single-port-two-ports-and-three-ports-vats-lobectomy-51298https://curecurrent.com/trials/evaluating-quality-of-life-in-patients-with-soft-tissue-sarcoma-presenting-with-metastatic-lung-disease-51299https://curecurrent.com/trials/phase-ii-study-of-imc-a12-in-patients-with-mesothelioma-who-have-been-previously-treated-with-chemotherapy-51300https://curecurrent.com/trials/phase-2-study-of-auy922-in-nsclc-patients-with-exon-20-insertion-mutations-in-egfr-51301https://curecurrent.com/trials/allogeneic-cellular-vaccine-1650-g-for-non-small-cell-lung-cancer-51302https://curecurrent.com/trials/microwave-ablation-in-ground-glass-nodules-51303https://curecurrent.com/trials/bibw-2992-afatinib-versus-chemotherapy-as-first-line-treatment-in-nsclc-with-egfr-mutation-51304https://curecurrent.com/trials/effects-of-matuzumab-in-combination-with-pemetrexed-for-the-treatment-of-advanced-lung-cancer-51305https://curecurrent.com/trials/effect-of-lung-cancer-diagnoses-on-family-behaviors-51306https://curecurrent.com/trials/chemotherapy-combination-with-local-radiotherapy-and-rhgm-csf-for-oligometastatic-stage-iv-nsclc-patients-51307https://curecurrent.com/trials/evaluation-of-lung-nodule-detection-with-artificial-intelligence-assisted-computed-tomography-in-north-china-51308https://curecurrent.com/trials/erlotinib-plus-tivantinib-arq-197-versus-single-agent-chemotherapy-in-locally-advanced-or-metastatic-non-small-cell-lung-51309https://curecurrent.com/trials/tivantinib-and-topotecan-hydrochloride-in-treating-patients-with-advanced-or-metastatic-solid-tumors-51310https://curecurrent.com/trials/gefitinib-and-berberine-in-the-first-line-treatment-of-lung-adenocarcinoma-with-egfr-mutation-51311https://curecurrent.com/trials/afatinib-plus-chemotherapy-against-esophageal-or-lung-squamous-cell-carcinoma-51312https://curecurrent.com/trials/paclitaxel-albumin-stabilized-nanoparticle-formulation-and-carboplatin-in-treating-patients-with-stage-iiib-stage-iv-or-51313https://curecurrent.com/trials/endobronchial-ultrasound-guided-transbronchial-needle-aspiration-ebus-tbna-for-mediastinal-re-staging-of-non-small-cell-51314https://curecurrent.com/trials/combination-checkpoint-inhibitor-plus-erlotinib-or-crizotinib-for-egfr-or-alk-mutated-stage-iv-non-small-cell-lung-cance-51315https://curecurrent.com/trials/role-of-activin-a-acta-in-the-human-cancer-cachexia-51316https://curecurrent.com/trials/novellusdx-cancer-early-detection-blood-test-clinical-trial-51317https://curecurrent.com/trials/enhancing-quality-of-life-in-patients-equip-intervention-for-patients-with-advanced-lung-cancer-51318https://curecurrent.com/trials/endobronchial-ultrasound-versus-mediastinoscopy-in-patients-with-non-small-cell-lung-cancer-nsclc-51319https://curecurrent.com/trials/auy922-for-advanced-alk-positive-nsclc-51320https://curecurrent.com/trials/second-line-erlotinib-tarceva-plus-digoxin-in-non-small-cell-lung-cancer-51321https://curecurrent.com/trials/novellusdx-functional-profiling-of-oncogenic-mutations-in-lung-cancer-patients-51322https://curecurrent.com/trials/nebulized-amphotericin-b-lipid-complex-in-invasive-pulmonary-aspergillosis-in-paediatric-patients-with-acute-leukaemia-51323https://curecurrent.com/trials/ganetespib-and-ziv-aflibercept-in-refractory-gastrointestinal-carcinomas-non-squamous-non-small-cell-lung-carcinomas-uro-51324https://curecurrent.com/trials/dect-ventilation-imaging-51325https://curecurrent.com/trials/post-treatment-surveillance-in-lung-cancer-51326https://curecurrent.com/trials/the-impact-of-lung-cancer-derived-fibroblasts-on-mast-cells-activation-51327https://curecurrent.com/trials/treatment-patterns-outcomes-and-resource-use-study-for-advanced-stage-non-small-cell-lung-cancer-squamous-and-non-squamo-51328https://curecurrent.com/trials/multimodal-prehabilitation-to-enhance-functional-recovery-after-lung-surgery-51329https://curecurrent.com/trials/5-fluorouracil-followed-by-interferon-alfa-2b-in-previously-treated-metastatic-gastrointestinal-kidney-or-lung-cancer-51330https://curecurrent.com/trials/effects-of-nonintubated-thoracoscopic-lobectomy-on-lung-protection-51331https://curecurrent.com/trials/integrated-versus-standard-palliative-care-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-51332https://curecurrent.com/trials/dignity-therapy-life-plan-in-patients-with-pancreatic-or-advanced-lung-cancer-51333https://curecurrent.com/trials/a-study-to-isolate-and-test-circulating-tumor-cells-using-the-clearcell-fx-ep-system-51334https://curecurrent.com/trials/pilot-study-to-evaluate-optical-frequency-domain-imaging-for-diagnosis-of-central-airway-disease-51335https://curecurrent.com/trials/trial-of-an-rnactive-derived-cancer-vaccine-in-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-51336https://curecurrent.com/trials/effects-of-succinylcholine-on-nonintubated-thoracoscopic-surgery-51337https://curecurrent.com/trials/study-of-fak-defactinib-and-pd-1-pembrolizumab-inhibition-in-advanced-solid-malignancies-fak-pd1-51338https://curecurrent.com/trials/a-phase-i-study-of-bkm120-and-everolimus-in-advanced-solid-malignancies-51339https://curecurrent.com/trials/calipso-calfactant-for-acute-lung-injury-in-pediatric-stem-cell-transplant-and-oncology-patients-51340https://curecurrent.com/trials/medi4736-with-selumetinib-for-kras-mutant-non-small-cell-lung-cancer-nsclc-51341https://curecurrent.com/trials/phase-ii-trial-of-pulsed-taxol-with-concurrent-thoracic-radiotherapy-adjuvant-chemo-in-stage-iii-nsclc-51342https://curecurrent.com/trials/assess-safety-efficacy-of-selumetinib-when-given-in-combination-with-standard-first-line-treatment-for-advanced-non-smal-51343https://curecurrent.com/trials/neoadjuvant-therapy-for-esophageal-cancer-and-cardiopulmonary-physiology-51344https://curecurrent.com/trials/t790m-mutation-on-ctdna-in-patients-with-nsclc-after-egfr-tki-failure-51345https://curecurrent.com/trials/anti-angiogenesis-combine-with-egfr-tki-in-advanced-non-squamous-non-small-cell-lung-cancer-51346https://curecurrent.com/trials/understanding-mechanisms-of-acquired-resistance-to-bibw2992-51347https://curecurrent.com/trials/radiation-therapy-and-stereotactic-radiosurgery-with-or-without-temozolomide-or-erlotinib-in-treating-patients-with-brai-51348https://curecurrent.com/trials/osimertinib-as-first-line-therapy-for-patients-with-late-stage-lung-cancer-51349https://curecurrent.com/trials/liquid-biopsy-for-detection-of-driver-mutation-in-nsclc-51350https://curecurrent.com/trials/captopril-in-treating-patients-with-non-small-cell-lung-cancer-or-limited-stage-small-cell-lung-cancer-that-has-been-pre-51351https://curecurrent.com/trials/phase-i-dose-escalation-and-expansion-of-oral-bay-1143269-in-combination-with-intravenous-docetaxel-51352https://curecurrent.com/trials/soft-tissue-detection-on-mri-cone-beam-ct-and-fan-beam-ct-and-integration-of-functional-mri-51353https://curecurrent.com/trials/comparison-of-the-effect-of-low-and-high-fraction-of-inspired-oxygen-on-postoperative-surgical-field-infection-51354https://curecurrent.com/trials/standard-chemotherapy-with-blueberry-powder-in-non-small-cell-lung-cancer-51355https://curecurrent.com/trials/oxaliplatin-in-combination-with-capecitabine-and-concurrent-radiation-therapy-in-non-small-cell-lung-cancer-51356https://curecurrent.com/trials/drug-sensitivity-correlation-between-patient-derived-organoid-model-and-clinical-response-in-nsclc-patients-51357https://curecurrent.com/trials/stereotactic-radiation-and-chemotherapy-in-lung-cancer-stereo-51358https://curecurrent.com/trials/afatinib-genomic-landscape-51359https://curecurrent.com/trials/using-trap-to-evaluate-the-effect-of-zometa-on-bone-metastasis-due-to-lung-cancer-51360https://curecurrent.com/trials/genomic-landscape-of-ceritinib-51361https://curecurrent.com/trials/using-iron-with-procrit-in-advanced-lung-cancer-patients-with-chemotherapy-induced-anemia-51362https://curecurrent.com/trials/intraoperative-imaging-of-pulmonary-adenocarcinoma-51363https://curecurrent.com/trials/early-diagnosis-of-pulmonary-nodules-51364https://curecurrent.com/trials/a-trial-of-pts-via-intratumoral-injection-in-patients-with-central-air-way-nsclc-severe-obstruction-51365https://curecurrent.com/trials/effects-of-open-thoracic-paravertebral-block-on-postoperative-analgesia-51366https://curecurrent.com/trials/asia-pdl1-study-among-nsclc-patients-51367https://curecurrent.com/trials/single-agent-versus-combination-chemotherapy-to-treat-high-risk-elderly-with-non-small-cell-lung-cancer-51368https://curecurrent.com/trials/evaluate-efficacy-of-respiratory-rehabilitation-personalized-mobile-services-for-respiratory-diseases-51369https://curecurrent.com/trials/a-trial-on-video-assisted-thoracoscopic-surgery-and-axillary-thoracotomy-for-resection-of-early-stage-non-small-cell-lun-51370https://curecurrent.com/trials/maekmoondong-tang-on-post-operative-cough-in-patients-with-lung-cancer-51371https://curecurrent.com/trials/a-case-control-study-to-verify-diagnostic-performance-of-aminoindex-technology-51372https://curecurrent.com/trials/combining-sbrt-and-immunotherapy-in-early-stage-nsclc-patients-planned-for-surgery-51373https://curecurrent.com/trials/pacritinib-in-patients-with-endothelial-growth-factor-egfr-mutant-non-small-cell-lung-cancer-nsclc-after-egfr-tyrosine-k-51374https://curecurrent.com/trials/technique-for-localization-of-pulmonary-nodules-using-spy-thoracoscope-system-51375https://curecurrent.com/trials/clinical-trial-of-thoracoscopic-lobecotmy-under-spontaneous-ventilating-anesthesia-51376https://curecurrent.com/trials/feasibility-of-a-minimally-invasive-thoracoscopic-ultrasound-for-localization-of-pulmonary-nodules-51377https://curecurrent.com/trials/effect-of-expression-of-cd74-and-vegf-on-outcome-of-treatment-in-patients-with-malignant-pleural-mesothelioma-51378https://curecurrent.com/trials/erlotinib-therapy-and-subsequent-development-of-mechanisms-of-secondary-resistance-in-patients-with-nsclc-51379https://curecurrent.com/trials/a-study-examining-maintenance-bevacizumab-avastin-monotherapy-in-participants-with-advanced-lung-adenocarcinoma-51380https://curecurrent.com/trials/safety-and-efficacy-of-belinostat-when-used-with-standard-of-care-chemotherapy-for-untreated-non-small-cell-lung-cancer-51381https://curecurrent.com/trials/visual-feedback-with-optical-sensing-a-feasibility-study-51382https://curecurrent.com/trials/surgery-for-early-lung-cancer-with-preoperative-erlotinib-tarceva-a-clinical-phase-ii-trial-select-51383https://curecurrent.com/trials/ebus-spectrum-analysis-51384https://curecurrent.com/trials/a-phase-1-2-trial-of-perifosine-in-the-treatment-of-non-small-cell-lung-cancer-51385https://curecurrent.com/trials/lung-cancer-information-study-lcis-r01-51386https://curecurrent.com/trials/n2-lung-cancer-project-neoadjuvant-treatment-followed-surgery-versus-chemoradiation-51387https://curecurrent.com/trials/anonymous-testing-of-pathology-specimens-for-brca-mutations-in-ashkenazi-jewish-individuals-who-have-cancer-51388https://curecurrent.com/trials/study-on-safety-and-pharmacokinetics-of-intravenous-f901318-for-fungal-prophylaxis-in-aml-patients-51389https://curecurrent.com/trials/the-effect-of-non-steroidal-anti-inflammatory-drug-naproxen-on-pleural-effusion-formation-after-lung-resection-51390https://curecurrent.com/trials/weekly-use-first-generation-egfr-tki-in-the-treatment-of-egfr-tki-acquired-resistance-non-small-cell-lung-cancer-nsclc-51391https://curecurrent.com/trials/incentive-spirometry-added-to-physiotherapy-to-reduce-postoperative-pulmonary-complications-after-lung-surgery-51392https://curecurrent.com/trials/ebus-score-validation-for-malignancy-51393https://curecurrent.com/trials/osimertinib-or-docetaxel-bevacizumab-as-third-line-treatment-in-egfr-t790m-mutated-non-small-cell-lung-cancer-51394https://curecurrent.com/trials/radiolabeled-monoclonal-antibody-therapy-in-treating-patients-with-stage-i-iiib-non-small-cell-lung-cancer-after-complet-51395https://curecurrent.com/trials/ruxolitinib-in-combination-with-pemetrexed-cisplatin-in-non-small-cell-lung-cancer-51396https://curecurrent.com/trials/egfr-mutations-on-ctdna-in-patients-with-advanced-nsclc-51397https://curecurrent.com/trials/a-study-to-explore-prognoses-of-nsclc-patients-complicated-with-oligometastases-51398https://curecurrent.com/trials/a-study-to-evaluate-effectiveness-and-safety-of-tyrosine-kinase-inhibitors-51399https://curecurrent.com/trials/erlotinib-tarceva-trademark-osi-774-in-treating-patients-with-advanced-non-small-cell-lung-cancer-51400https://curecurrent.com/trials/observational-study-of-patients-with-locally-advanced-or-metastatic-nsclc-non-small-cell-lung-cancer-51401https://curecurrent.com/trials/strides-for-life-i-increasing-physical-activity-in-stage-1-lung-cancer-patients-51402https://curecurrent.com/trials/docetaxel-with-or-without-tak-117-mln1117-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-51403https://curecurrent.com/trials/neoadjuvant-chemo-for-non-metastatic-non-small-cell-lung-cancer-51404https://curecurrent.com/trials/uncommon-egfr-azd9291-51405https://curecurrent.com/trials/an-expanded-access-study-of-brigatinib-for-patients-with-alk-positive-advanced-non-small-cell-lung-cancer-51406https://curecurrent.com/trials/the-effect-of-berries-on-lung-cancer-tumors-51407https://curecurrent.com/trials/evaluation-of-respiratory-motion-corrected-cone-beam-ct-in-radiation-treatment-of-thoracic-and-abdominal-cancers-51408https://curecurrent.com/trials/seretide-vs-flixotide-in-mild-persistent-asthma-ginaii-51409https://curecurrent.com/trials/a-study-of-bevacizumab-versus-placebo-in-combination-with-carboplatin-paclitaxel-in-participants-with-advanced-or-recurr-51410https://curecurrent.com/trials/intraoperative-imaging-of-thoracic-malignancies-with-indocyanine-green-51411https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer-51412https://curecurrent.com/trials/phase-i-of-vorinostat-iressa-combined-therapy-on-resistance-by-bim-polymorphysim-in-egfr-mutant-lung-cancer-51413https://curecurrent.com/trials/transformation-into-small-cell-lung-cancer-a-mode-of-resistance-to-treatment-51414https://curecurrent.com/trials/incidence-of-scln-metastasis-in-patients-referred-for-ebus-tbna-51415https://curecurrent.com/trials/a-study-of-intravenous-xmt-1001-in-patients-with-advanced-solid-tumors-51416https://curecurrent.com/trials/apatinib-plus-docetaxel-in-advanced-non-squamous-non-small-cell-lung-cancer-nsclc-51417https://curecurrent.com/trials/carboplatin-and-paclitaxel-albumin-stabilized-nanoparticle-formulation-followed-by-radiation-therapy-and-erlotinib-in-tr-51418https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-recurrent-or-stage-iv-lung-cancer-51419https://curecurrent.com/trials/detecting-radiation-induced-cardiac-toxicity-after-non-small-cell-lung-cancer-radiotherapy-51420https://curecurrent.com/trials/a-study-of-cdx-1127-varlilumab-in-patients-with-select-solid-tumor-types-or-hematologic-cancers-51421https://curecurrent.com/trials/high-dose-gefitinib-for-the-treatment-of-carcinomatous-meningitis-in-adult-patients-with-non-small-cell-lung-cancer-and-51422https://curecurrent.com/trials/elective-simultaneous-modulated-accelerated-brain-radiation-therapy-for-nsclcs-with-limited-brain-metastases-51423https://curecurrent.com/trials/suberoylanilide-hydroxamic-acid-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-51424https://curecurrent.com/trials/clinical-trial-for-post-marketing-evaluation-of-sheng-bai-oral-liquid-51425https://curecurrent.com/trials/apatinib-in-combination-with-docetaxel-for-patients-with-advanced-nsclc-51426https://curecurrent.com/trials/significance-of-ultrasound-elastography-in-lymph-node-51427https://curecurrent.com/trials/efficacy-trial-comparing-zd6474-with-erlotinib-in-nsclc-after-failure-of-at-least-one-prior-chemotherapy-51428https://curecurrent.com/trials/long-term-cancer-risk-in-the-randomised-oslo-diet-and-antismoking-study-51429https://curecurrent.com/trials/removal-of-lung-nodules-after-being-marked-with-a-microcoil-51430https://curecurrent.com/trials/alcohol-and-tobacco-consumption-in-patients-with-head-and-neck-cancer-interest-of-an-addiction-support-51431https://curecurrent.com/trials/a-clinical-research-of-nk-cell-infusion-combined-with-chemotherapy-in-the-treatment-of-non-small-cell-lung-cancer-51432https://curecurrent.com/trials/anti-tac-fv-pe38-lmb-2-to-treat-chronic-lymphocytic-leukemia-51433https://curecurrent.com/trials/induction-therapy-with-intercalated-tyrosine-kinase-inhibitor-tki-and-chemotherapy-in-nsclc-with-activating-epidermal-gr-51434https://curecurrent.com/trials/s0509-azd2171-in-treating-patients-with-malignant-pleural-mesothelioma-that-cannot-be-removed-by-surgery-51435https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-trigger-51436https://curecurrent.com/trials/study-of-patritumab-in-combination-with-erlotinib-in-subjects-with-locally-advanced-or-metastatic-non-small-cell-lung-ca-51437https://curecurrent.com/trials/specialized-radiation-therapy-and-chemotherapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-that-canno-51438https://curecurrent.com/trials/a-trial-with-metronomic-low-dose-treosulfan-pioglitazone-and-clarithromycin-versus-standard-treatment-in-nsclc-51439https://curecurrent.com/trials/lenalidomide-maintenance-therapy-in-stage-iiib-iv-non-small-cell-lung-cancer-51440https://curecurrent.com/trials/icotinib-combined-with-dihydroaremisinin-dha-therapy-in-patients-with-advanced-nsclc-51441https://curecurrent.com/trials/a-vaccine-trial-for-patients-with-stage-iiib-iv-or-recurrent-non-small-cell-lung-cancer-51442https://curecurrent.com/trials/a-study-of-imgn901-for-patients-with-advanced-solid-tumors-and-extensive-stage-small-cell-lung-cancer-51443https://curecurrent.com/trials/strategies-for-maintenance-therapies-in-advanced-non-small-cell-lung-cancer-51444https://curecurrent.com/trials/a-study-of-apatinib-plus-docetaxel-for-treatment-of-advanced-non-squamous-non-small-cell-lung-cancer-with-bone-metastase-51445https://curecurrent.com/trials/phase-i-imaging-study-evaluating-gem-cis-or-gem-carbo-for-participants-with-non-small-cell-lung-cancer-mk-0000-083-am3-51446https://curecurrent.com/trials/open-label-multicenter-randomized-phase-ii-trial-of-treatment-with-cisplatin-and-pemetrexed-or-cisplatin-and-oral-vinore-51447https://curecurrent.com/trials/the-continuation-of-gefitinib-treatment-beyond-progression-in-non-small-cell-lung-cancer-patients-with-egfr-mutation-51448https://curecurrent.com/trials/irinotecan-and-carboplatin-in-treating-patients-with-metastatic-or-recurrent-small-cell-lung-cancer-51449https://curecurrent.com/trials/osi-774-tarceva-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-51450https://curecurrent.com/trials/radiation-therapy-and-cardiac-enzymes-51451https://curecurrent.com/trials/erlotinib-and-chemotherapy-for-patients-with-stage-ib-iiia-nsclc-with-egfr-mutations-econ-51452https://curecurrent.com/trials/study-of-dovitinib-and-biomarkers-in-advanced-non-small-cell-lung-cancer-or-advanced-colorectal-cancer-51453https://curecurrent.com/trials/everolimus-carboplatin-and-etoposide-in-treating-patients-with-small-cell-lung-cancer-or-other-advanced-solid-tumors-51454https://curecurrent.com/trials/maintaining-erbb-blockade-in-egfr-mutated-lung-cancer-51455https://curecurrent.com/trials/cisplatin-etoposide-and-pi3k-inhibitor-bkm120-in-treating-patients-with-advanced-solid-tumors-or-small-cell-lung-cancer-51456https://curecurrent.com/trials/symptom-collection-of-lung-cancer-patients-51457https://curecurrent.com/trials/clinical-study-of-microdosing-carboplatin-in-lung-or-bladder-cancer-51458https://curecurrent.com/trials/study-of-cisplatin-and-pemetrexed-in-combination-with-panobinostat-in-solid-tumors-51459https://curecurrent.com/trials/effect-of-preoperative-budesonide-inhalation-on-arterial-blood-oxygenation-and-intrapulmonary-shunt-during-olv-51460https://curecurrent.com/trials/korean-lung-cancer-screening-project-51461https://curecurrent.com/trials/ketogenic-diet-with-chemoradiation-for-lung-cancer-ketolung-51462https://curecurrent.com/trials/ebus-tbna-rte-vs-radiography-in-staging-of-nsclc-51463https://curecurrent.com/trials/patient-navigation-for-lung-screening-at-mgh-community-health-centers-51464https://curecurrent.com/trials/a-phase-2-trial-of-amg-706-or-bevacizumab-in-combination-with-chemo-for-advanced-nsclc-51465https://curecurrent.com/trials/predictors-for-bronchoalveolar-lavage-bal-recovery-rate-derived-from-quantified-computed-tomography-qct-51466https://curecurrent.com/trials/a-study-evaluates-the-safety-pharmacokinetics-and-efficacy-of-wx-0593-in-advanced-solid-tumor-patients-51467https://curecurrent.com/trials/effect-of-fas-and-fas-ligand-polymorphisms-on-patients-with-platinum-based-treated-malignant-pleural-mesothelioma-51468https://curecurrent.com/trials/apatinib-in-the-treatment-of-patients-with-egfr-t790m-negative-nsclc-51469https://curecurrent.com/trials/ct-scan-guide-percutaneous-biopsy-of-lytic-bone-metastases-of-lung-cancer-contribution-in-pathology-diagnosis-and-molecu-51470https://curecurrent.com/trials/topotecan-and-bevacizumab-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-that-did-not-respo-51471https://curecurrent.com/trials/carboplatin-and-gemcitabine-with-bevacizumab-every-2-weeks-for-stage-iiib-iv-non-small-cell-lung-cancer-51472https://curecurrent.com/trials/efficacy-and-safety-of-oral-treatment-with-bibf-1120-es-in-advanced-non-small-cell-lung-cancer-51473https://curecurrent.com/trials/effects-of-positive-end-expiratory-pressure-on-biventricular-function-during-one-lung-ventilation-51474https://curecurrent.com/trials/carboplatin-gemcitabine-and-thalidomide-in-patients-undergoing-surgery-for-stage-ii-or-iii-non-small-cell-lung-cancer-51475https://curecurrent.com/trials/study-of-biologic-materials-from-the-mediastinal-lymph-nodes-from-patients-with-lung-disease-51476https://curecurrent.com/trials/osi-774-in-african-american-patients-with-advanced-and-previously-treated-non-small-cell-lung-cancer-51477https://curecurrent.com/trials/radiation-therapy-combined-with-paclitaxel-and-carboplatin-in-treating-patients-with-stage-iii-non-small-cell-lung-cance-51478https://curecurrent.com/trials/cisplatin-etoposide-and-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-51479https://curecurrent.com/trials/gefitinib-combine-radiotherapy-as-therapy-for-patients-with-nsclc-harbouring-sensitive-mutations-of-egfr-51480https://curecurrent.com/trials/pembrolizumab-mk-3475-as-maintainance-in-treated-patients-with-unresectable-stage-iii-nsclc-51481https://curecurrent.com/trials/study-of-s-588410-after-adjuvant-chemotherapy-for-completely-resected-non-small-cell-lung-cancer-51482https://curecurrent.com/trials/safety-of-lead-radiotherapy-plus-chemoradiation-in-patients-with-bulky-stage-iii-non-small-cell-lung-cancer-51483https://curecurrent.com/trials/enoxaparin-thromboprophylaxis-in-cancer-patients-with-elevated-tissue-factor-bearing-microparticles-51484https://curecurrent.com/trials/surgery-with-or-without-chemotherapy-for-stage-i-nsclc-with-micropapillary-component-20-51485https://curecurrent.com/trials/study-of-apatinib-as-the-maintenance-therapy-in-advanced-lung-adenocarcinoma-51486https://curecurrent.com/trials/apatinib-in-advanced-non-squamous-nsclc-51487https://curecurrent.com/trials/evaluation-of-gender-differences-on-the-psychosocial-and-economic-impact-in-patients-with-advanced-non-small-cell-lung-c-51488https://curecurrent.com/trials/a-phase-ii-trial-of-cisplatin-docetaxel-induction-plus-concurrent-3-d-conformal-radiotherapy-and-weekly-chemotherapy-51489https://curecurrent.com/trials/phase-i-ii-calcitriol-in-lung-cancer-51490https://curecurrent.com/trials/intravenous-indocyanine-green-for-localization-of-intra-thoracic-lesions-51491https://curecurrent.com/trials/apatinib-plus-radiotherapy-for-patients-with-brain-metastases-from-non-small-cell-lung-cancer-51492https://curecurrent.com/trials/hippocampus-sparing-wbrt-and-simultaneous-integrated-boost-for-multiple-brain-metastases-from-nsclc-51493https://curecurrent.com/trials/a-dose-escalation-study-to-investigate-the-safety-pharmacokinetics-pk-pharmacodynamics-pd-and-clinical-activity-of-gsk52-51494https://curecurrent.com/trials/hypofractionated-proton-beam-radiation-therapy-paclitaxel-and-carboplatin-in-treating-patients-with-stage-ii-iii-non-sma-51495https://curecurrent.com/trials/bortezomib-paclitaxel-carboplatin-and-radiation-therapy-for-non-small-cell-lung-cancer-51496https://curecurrent.com/trials/azd0530-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-51497https://curecurrent.com/trials/apatinib-and-etoposide-as-the-maintenance-therapy-in-extensive-stage-small-cell-lung-cancer-after-first-line-chemotherap-51498https://curecurrent.com/trials/stereotactic-body-radiotherapy-sbrt-versus-stereotactic-body-proton-therapy-sbpt-51499https://curecurrent.com/trials/durvalumab-and-tremelimumab-for-adjuvant-therapy-of-resected-nsclc-51500https://curecurrent.com/trials/docetaxel-and-bortezomib-in-treating-patients-with-progressive-or-recurrent-non-small-cell-lung-cancer-51501https://curecurrent.com/trials/pioglitazone-hydrochloride-in-treating-patients-with-stage-ia-iiia-non-small-cell-lung-cancer-51502https://curecurrent.com/trials/inositol-in-preventing-lung-cancer-in-current-or-former-smokers-with-bronchial-dysplasia-51503https://curecurrent.com/trials/ipi-504-in-nsclc-patients-with-alk-translocations-51504https://curecurrent.com/trials/combination-of-platinum-doublets-and-hypofractionated-radiotherapy-in-nsclc-51505https://curecurrent.com/trials/pulmonary-ventilation-perfusion-imaging-for-the-prediction-of-postoperative-residual-pulmonary-function-51506https://curecurrent.com/trials/bronchial-artery-infusion-of-gemcitabine-in-treating-patients-with-recurrent-or-progressive-non-small-cell-lung-cancer-51507https://curecurrent.com/trials/oxaliplatin-docetaxel-and-radiation-therapy-in-treating-patients-with-unresectable-stage-ii-iii-or-recurrent-nsclc-51508https://curecurrent.com/trials/genotype-driven-treatment-of-advanced-non-small-cell-lung-cancer-based-on-mrna-expression-of-ercc1-rrm1-as-first-line-ch-51509https://curecurrent.com/trials/carboplatin-paclitaxel-selenomethionine-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-ca-51510https://curecurrent.com/trials/safety-of-low-dose-iv-contrast-ct-scanning-in-chronic-kidney-disease-51511https://curecurrent.com/trials/intercalating-and-maintenance-gefitinib-in-combination-with-chemotherapy-for-advanced-egfr-mutant-nsclc-51512https://curecurrent.com/trials/mechanisms-of-ethnic-racial-differences-in-lung-cancer-due-to-cigarette-smoking-clinical-and-biomarkers-core-51513https://curecurrent.com/trials/npi-0052-and-vorinostat-in-patients-with-non-small-cell-lung-cancer-pancreatic-cancer-melanoma-or-lymphoma-51514https://curecurrent.com/trials/a-study-of-linifanib-abt-869-in-combination-with-carboplatin-paclitaxel-in-japanese-subjects-with-non-small-cell-lung-ca-51515https://curecurrent.com/trials/a-phase-1b-study-with-volociximab-in-combination-with-carboplatin-and-paclitaxel-in-first-line-advanced-non-small-cell-l-51516https://curecurrent.com/trials/impact-of-pulmonary-follow-up-after-stem-cell-graft-51517https://curecurrent.com/trials/apatinib-combine-with-platinum-based-doublet-chemotherapy-for-first-line-treatment-of-advanced-nsclc-51518https://curecurrent.com/trials/efficiency-of-icotinib-in-plasma-ctdna-egfr-mutation-positive-patients-diagnosed-with-lung-cancer-51519https://curecurrent.com/trials/ir-guided-ablation-irga-combined-with-stereotactic-ablative-radiation-sabr-for-large-lung-tumors-51520https://curecurrent.com/trials/a-phase-i-study-of-pazopanib-with-either-erlotinib-or-pemetrexed-in-patients-with-advanced-solid-tumors-51521https://curecurrent.com/trials/a-phase-ii-trial-of-lapatinib-tykerb-pemetrexed-alimta-in-advanced-non-small-cell-lung-cancer-with-an-initial-dose-findi-51522https://curecurrent.com/trials/ofatumumab-in-japanese-patients-with-cd20-positive-follicular-lymphoma-or-chronic-lymphocytic-leukemia-51523https://curecurrent.com/trials/a-study-to-determine-if-two-different-versions-of-topotecan-have-the-same-potency-in-patients-with-advanced-solid-tumors-51524https://curecurrent.com/trials/a-phase-i-open-label-study-of-pazopanib-in-combination-with-gemcitabine-and-gemcitabine-plus-cisplatin-for-advanced-soli-51525https://curecurrent.com/trials/egfr-mutation-positive-nsclc-patients-with-gefitinib-and-thalidomide-51526https://curecurrent.com/trials/study-of-pazopanib-and-paclitaxel-in-advanced-non-small-cell-lung-cancer-51527https://curecurrent.com/trials/nab-paclitaxel-versus-paclitaxel-plus-carboplatin-in-advanced-squamous-cell-non-small-cell-lung-cancer-51528https://curecurrent.com/trials/trial-of-gsk1120212-and-gsk1120212-in-combination-with-gem-in-japanese-subjects-with-solid-tumors-51529https://curecurrent.com/trials/health-education-counseling-with-or-without-bupropion-in-helping-african-americans-stop-smoking-51530https://curecurrent.com/trials/next-generation-sequencing-of-small-cell-lung-cancer-to-identify-actionable-targets-for-treatment-51531https://curecurrent.com/trials/explore-intra-tumor-heterogeneity-and-prognostic-value-of-postoperative-blood-ctdna-of-a-a-stage-non-squamous-nsclc-base-51532https://curecurrent.com/trials/a-study-of-the-gsk-mek-inhibitor-gsk1120212-and-everolimus-in-cancer-subjects-51533https://curecurrent.com/trials/sleep-apnea-in-lung-cancer-a-prospective-study-51534https://curecurrent.com/trials/bicentric-prospective-study-evaluating-bronchial-thermoplasty-in-a-patient-presenting-severe-uncontrolled-asthma-51535https://curecurrent.com/trials/hypofractionated-vs-conventionally-fractionated-concurrent-crt-for-unresectable-stage-iii-nsclc-51536https://curecurrent.com/trials/comparison-of-cost-effectiveness-of-continuation-maintenance-therapy-with-six-cycles-of-pemetrexed-versus-pemetrexed-unt-51537https://curecurrent.com/trials/a-clinical-trial-testing-the-efficacy-of-crizotinib-versus-standard-chemotherapy-pemetrexed-plus-cisplatin-or-carboplati-51538https://curecurrent.com/trials/ph2-nab-paclitaxel-with-gemcitabine-to-determine-efficacy-in-advanced-non-squamous-nsclc-51539https://curecurrent.com/trials/a-new-pathway-with-bronchoscopic-or-oesophageal-ultrasound-for-lung-cancer-diagnosis-and-staging-boost-51540https://curecurrent.com/trials/carboplatin-pemetrexed-disodium-and-bevacizumab-for-patients-with-stage-iii-or-iv-non-small-cell-lung-cancer-who-are-lig-51541https://curecurrent.com/trials/safety-and-efficacy-of-anamorelin-hcl-in-patients-with-non-small-cell-lung-cancer-cachexia-romana-1-51542https://curecurrent.com/trials/egfr-tki-concurrent-with-without-wbrt-in-brain-metastasis-from-nsclc-51543https://curecurrent.com/trials/pet-response-during-chemoradiation-of-lung-cancer-51544https://curecurrent.com/trials/safety-and-efficacy-of-anamorelin-hcl-in-patients-with-non-small-cell-lung-cancer-cachexia-romana-2-51545https://curecurrent.com/trials/a-prospective-observational-trial-on-the-diagnostic-and-prognostic-of-lm-51546https://curecurrent.com/trials/crizotinib-in-pretreated-metastatic-non-small-cell-lung-cancer-with-met-amplification-or-ros1-translocation-metros-51547https://curecurrent.com/trials/edit-management-feasibility-trial-51548https://curecurrent.com/trials/a-study-examining-long-response-in-lung-cancer-patients-treated-with-tarceva-erlotinib-51549https://curecurrent.com/trials/fulvestrant-and-anastrozole-as-consolidation-therapy-in-postmenopausal-women-with-advanced-non-small-cell-lung-cancer-51550https://curecurrent.com/trials/phase-ii-trial-of-rad001-everolimus-in-previously-treated-small-cell-lung-cancer-51551https://curecurrent.com/trials/efficacy-and-safety-study-of-abp-215-compared-with-bevacizumab-in-patients-with-advanced-non-small-cell-lung-cancer-51552https://curecurrent.com/trials/fludeoxyglucose-f-18-in-detecting-lymph-node-metastasis-in-patients-with-stage-i-or-stage-ii-non-small-cell-lung-cancer-51553https://curecurrent.com/trials/vaccine-therapy-in-patients-with-stages-iiib-iv-non-small-cell-lung-cancer-who-have-finished-first-line-chemotherapy-51554https://curecurrent.com/trials/lung-cancer-surgery-decisions-against-life-saving-care-the-intervention-51555https://curecurrent.com/trials/proteome-based-immunotherapy-of-lung-cancer-brain-metastases-51556https://curecurrent.com/trials/curative-study-of-chinese-traditional-medicine-to-treat-lung-cancer-51557https://curecurrent.com/trials/comparison-of-robot-assisted-thoracic-surgery-with-video-assisted-thoracic-surgery-in-case-of-lung-cancer-51558https://curecurrent.com/trials/phase-i-vorinostat-concurrent-with-stereotactic-radiosurgery-srs-in-brain-metastases-from-non-small-cell-lung-cancer-51559https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-pharmacology-of-dnib0600a-in-participants-with-platinum-sensitive-ovarian-cancer-or-n-51560https://curecurrent.com/trials/evaluation-of-the-texas-wellness-incentives-and-navigation-win-project-51561https://curecurrent.com/trials/study-to-investigate-the-absorption-metabolism-and-excretion-of-14c-ac0010-in-patients-with-advanced-nsclc-51562https://curecurrent.com/trials/me-344-given-in-combination-with-hycamtin-in-patients-with-solid-tumors-51563https://curecurrent.com/trials/etanercept-in-treating-young-patients-with-idiopathic-pneumonia-syndrome-after-undergoing-a-donor-stem-cell-transplant-51564https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-stage-iv-lung-cancer-51565https://curecurrent.com/trials/imaging-biomarker-in-cancer-drug-induced-ild-51566https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-recurrent-or-extensive-stage-small-cell-lung-cancer-51567https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-recurrent-or-stage-iv-lung-cancer-51568https://curecurrent.com/trials/a-phase-ii-study-of-cabozantinib-xl184-therapy-in-castrate-resistant-prostate-cancer-crpc-with-visceral-metastases-51569https://curecurrent.com/trials/a-study-comparing-the-combination-of-the-best-supportive-care-plus-e7080-versus-best-supportive-care-alone-in-patients-w-51570https://curecurrent.com/trials/early-prediction-of-pathology-response-of-chemoradiotherapy-with-flt-pet-51571https://curecurrent.com/trials/clinical-efficacy-and-safety-of-nk-and-nkt-cells-infusion-in-patients-with-non-small-cell-lung-cancer-51572https://curecurrent.com/trials/phase-i-ii-study-of-fractionated-stereotactic-radiotherapy-for-medically-inoperable-nsclc-or-metastatic-lung-tumours-51573https://curecurrent.com/trials/confocal-laser-endomicroscopy-in-pleural-malignancies-51574https://curecurrent.com/trials/computed-tomography-ct-guided-lung-biopsy-core-or-fine-needle-aspiration-51575https://curecurrent.com/trials/pre-post-study-for-supporting-appropriate-implementation-of-lung-cancer-screening-51576https://curecurrent.com/trials/optical-biopsy-for-thoracic-lymph-nodes-51577https://curecurrent.com/trials/microwave-plus-chemotherapy-versus-chemotherapy-for-advanced-nsclc-51578https://curecurrent.com/trials/autologous-redirected-rna-meso-cir-t-cells-51579https://curecurrent.com/trials/study-of-anlotinib-in-patients-with-advanced-non-small-cell-lung-cancer-alter0303-51580https://curecurrent.com/trials/afatinib-in-egfr-nsclc-recurrent-or-stage-iv-patients-with-poor-performance-status-ecog-2-or-3-51581https://curecurrent.com/trials/a-study-of-bevacizumab-in-combination-with-standard-of-care-treatment-in-participants-with-advanced-non-squamous-non-sma-51582https://curecurrent.com/trials/assessment-of-a-tool-for-decision-making-in-case-of-worsening-condition-of-cancer-patients-51583https://curecurrent.com/trials/recombinant-interleukin-15-in-treating-patients-with-advanced-melanoma-kidney-cancer-non-small-cell-lung-cancer-or-squam-51584https://curecurrent.com/trials/treatment-of-non-small-cell-lung-cancer-with-cytokine-induced-killer-cik-cells-blocked-by-pd-1-antibody-51585https://curecurrent.com/trials/lung-cancer-early-molecular-assessment-trial-51586https://curecurrent.com/trials/feasibility-of-cetuximab-associated-with-concomitant-radio-chemotherapy-in-patients-with-locally-advanced-non-small-cell-51587https://curecurrent.com/trials/anamorelin-hcl-in-the-treatment-of-non-small-cell-lung-cancer-cachexia-nsclc-c-an-extension-study-romana-3-51588https://curecurrent.com/trials/plan-for-systematic-identification-of-lung-cancers-of-occupational-origin-implementation-study-51589https://curecurrent.com/trials/postoperative-nsclc-treated-with-integrated-medicine-base-on-circulating-tumor-cell-detection-51590https://curecurrent.com/trials/nivolumab-in-patients-with-recurrent-malignant-mesothelioma-51591https://curecurrent.com/trials/non-small-cell-lung-cancer-study-us75-z-pact-51592https://curecurrent.com/trials/single-dose-study-of-14c-lorlatinib-pf-06463922-metabolism-in-healthy-male-volunteers-51593https://curecurrent.com/trials/erlotinib-as-neoadjuvant-treatment-in-patients-with-stage-a-n2-nsclc-with-activating-egfr-mutation-51594https://curecurrent.com/trials/prevalence-and-incidence-of-central-airway-obstruction-in-advanced-lung-cancer-51595https://curecurrent.com/trials/prevalence-of-sleep-disordered-breathing-in-a-lung-cancer-screening-cohort-51596https://curecurrent.com/trials/aspet-study-an-observational-study-of-tarceva-erlotinib-in-first-line-in-patients-with-advanced-non-small-cell-lung-canc-51597https://curecurrent.com/trials/proton-therapy-with-chemotherapy-for-stage-iii-non-small-cell-lung-cancer-lu02-51598https://curecurrent.com/trials/phase-ii-study-of-afatinib-as-third-or-further-line-treatment-for-patients-with-stage-iv-bronchial-adenocarcinoma-harbor-51599https://curecurrent.com/trials/study-of-apatinib-as-third-line-and-later-therapy-in-patients-with-small-cell-lung-cancer-sclc-51600https://curecurrent.com/trials/registry-measuring-the-impact-of-adding-rna-expression-testing-on-referral-decisions-in-early-stage-lung-cancer-patients-51601https://curecurrent.com/trials/registry-measuring-impact-of-rna-expression-testing-on-treatment-decisions-in-early-stage-lung-cancer-and-assessing-the-51602https://curecurrent.com/trials/phase-1-combination-study-of-mm-151-with-mm-121-mm-141-or-trametinib-51603https://curecurrent.com/trials/fast-tracking-in-vats-lobectomy-a-prospective-historically-controlled-propensity-matched-clinical-trial-51604https://curecurrent.com/trials/manuka-honey-in-preventing-esophagitis-related-pain-in-patients-receiving-chemotherapy-and-radiation-therapy-for-lung-ca-51605https://curecurrent.com/trials/study-to-evaluate-resistance-mechanisms-and-real-world-pharmacoeconomics-of-crizotinib-in-nsclc-patients-51606https://curecurrent.com/trials/registry-trial-to-determine-pcle-image-interpretation-criteria-and-preliminary-accuracy-in-the-lung-51607https://curecurrent.com/trials/the-clinical-trial-of-gefitinib-non-small-cell-lung-cancer-51608https://curecurrent.com/trials/sym004-in-combination-with-nivolumab-versus-nivolumab-monotherapy-in-egfr-amplified-squamous-non-small-cell-lung-cancer-51609https://curecurrent.com/trials/phase-1b-2-study-of-carfilzomib-carboplatin-and-etoposide-in-patients-with-previously-untreated-extensive-stage-small-ce-51610https://curecurrent.com/trials/imrt-and-timing-in-combination-with-egfrtki-for-stage-iv-non-small-cell-lung-cancer-51611https://curecurrent.com/trials/bibf-1120-as-second-line-treatment-for-small-cell-lung-cancer-51612https://curecurrent.com/trials/mri-adaptive-replanning-using-viewray-51613https://curecurrent.com/trials/gefitinib-with-or-without-simvastatin-in-non-small-cell-lung-cancer-nsclc-51614https://curecurrent.com/trials/a-study-of-standard-treatment-enoxaparin-in-small-cell-lung-cancer-51615https://curecurrent.com/trials/tecemotide-following-concurrent-chemo-radiotherapy-for-non-small-cell-lung-cancer-51616https://curecurrent.com/trials/study-of-gemcitabine-carboplatin-first-line-chemotherapy-apatorsen-in-advanced-squamous-cell-lung-cancers-51617https://curecurrent.com/trials/cyclin-b1-peptide-pulsed-autologous-dendritic-cell-vaccine-for-resectable-non-small-cell-lung-cancer-51618https://curecurrent.com/trials/a-study-of-the-gene-mutation-status-in-cerebrospinal-fluid-blood-and-tumor-tissue-of-non-small-cell-lung-cancer-patients-51619https://curecurrent.com/trials/computer-assisted-counseling-in-helping-african-american-smokers-stop-smoking-51620https://curecurrent.com/trials/registry-for-the-evolution-of-lung-cancer-therapy-implementation-and-outcomes-now-51621https://curecurrent.com/trials/s0802-topotecan-with-or-without-aflibercept-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-51622https://curecurrent.com/trials/circulating-tumor-dna-in-patients-at-high-risk-for-lung-cancer-51623https://curecurrent.com/trials/vitamin-d-loading-dose-in-advanced-lung-cancer-51624https://curecurrent.com/trials/the-efficacy-and-safety-of-apatinib-in-heavily-pretreated-advanced-non-squamous-non-small-cell-lung-cancer-51625https://curecurrent.com/trials/combination-of-the-hedgehog-inhibitor-lde225-with-etoposide-and-cisplatin-in-the-first-line-treatment-of-patients-with-e-51626https://curecurrent.com/trials/89zr-labeled-pembrolizumab-in-patients-with-non-small-cell-lung-cancer-51627https://curecurrent.com/trials/comfort-caregiver-intervention-in-improving-communication-and-reducing-distress-in-caregivers-of-patients-with-lung-canc-51628https://curecurrent.com/trials/phase-1b-2-study-of-carfilzomib-in-relapsed-solid-tumors-multiple-myeloma-or-lymphoma-51629https://curecurrent.com/trials/powered-surgical-stapler-in-vats-lung-resection-procedures-in-china-51630https://curecurrent.com/trials/next-generation-sequencing-of-small-cell-lung-cancer-to-identify-susceptibility-gene-and-to-assess-treatment-51631https://curecurrent.com/trials/novottf-100a-therapy-for-refractory-cns-involved-small-cell-lung-cancer-51632https://curecurrent.com/trials/comparison-of-qpcr-to-ihc-and-fish-for-detection-of-alk-fusion-mutations-in-ffpe-tissue-from-nsclc-patients-51633https://curecurrent.com/trials/study-of-tumor-samples-from-patients-with-lung-cancer-51634https://curecurrent.com/trials/effectiveness-and-safety-of-adding-bevacizumab-to-first-line-chemotherapy-in-lung-cancer-patients-with-stable-disease-51635https://curecurrent.com/trials/battle-program-erlotinib-in-previously-treated-subjects-with-advanced-nsclc-51636https://curecurrent.com/trials/a-prognosis-and-predicting-genetic-study-of-lung-cancer-51637https://curecurrent.com/trials/inhalation-slit-cisplatin-liposomal-for-the-treatment-of-osteosarcoma-metastatic-to-the-lung-51638https://curecurrent.com/trials/characterization-of-circulating-tumor-cells-captured-by-c-met-ctc-met-51639https://curecurrent.com/trials/vigil-nivolumab-in-advanced-non-small-cell-lung-cancer-51640https://curecurrent.com/trials/avadeno-study-an-observational-study-of-first-line-avastin-bevacizumab-in-patients-with-adenocarcinoma-of-the-lung-51641https://curecurrent.com/trials/study-to-evaluate-using-nelfinavir-with-chemoradiation-for-non-small-cell-lung-cancer-51642https://curecurrent.com/trials/high-dose-icotinib-in-advanced-non-small-cell-lung-cancer-with-egfr-21-exon-mutation-51643https://curecurrent.com/trials/the-effectiveness-of-using-preventive-multimedia-teaching-program-in-lung-cancer-women-receiving-targeted-therapy-on-ski-51644https://curecurrent.com/trials/safety-and-pharmacology-of-snx-5422-plus-carboplatin-and-paclitaxel-in-subjects-with-solid-tumors-51645https://curecurrent.com/trials/study-of-nab-paclitaxel-in-sensitive-and-refractory-relapsed-sclc-51646https://curecurrent.com/trials/the-utility-of-fdg-pet-for-radiation-treatment-in-nsclc-51647https://curecurrent.com/trials/the-value-of-surgical-mediastinal-staging-in-clinical-n1-lung-cancer-51648https://curecurrent.com/trials/the-predicted-potential-of-quantitative-t-cell-repertoire-tcr-in-anti-pd-l1-treatment-in-nsclc-patients-51649https://curecurrent.com/trials/the-randomized-controlled-clinical-trial-of-kushen-injection-51650https://curecurrent.com/trials/radical-pleurectomy-decortication-pd-and-intensity-modulated-radiotherapy-imrt-51651https://curecurrent.com/trials/preventive-effects-of-zoledronic-acid-on-bone-metastasis-in-patients-with-stage-iiib-and-iv-lung-cancer-51652https://curecurrent.com/trials/crizotinib-expanded-access-protocol-for-ros1-positive-nsclc-51653https://curecurrent.com/trials/protein-and-rna-expression-patterns-in-predicting-response-to-treatment-in-patients-with-lung-cancer-51654https://curecurrent.com/trials/lung-rehabilitation-in-treating-patients-with-chronic-obstructive-pulmonary-disease-who-are-undergoing-surgery-for-lung-51655https://curecurrent.com/trials/a-study-of-dacomitinib-pf-00299804-in-patients-with-advanced-non-small-cell-lung-cancer-51656https://curecurrent.com/trials/chloroquine-as-an-anti-autophagic-radiosensitizing-drug-in-stage-i-iii-small-cell-lung-cancer-51657https://curecurrent.com/trials/a-multicenter-randomized-phase-iii-study-comparing-second-line-treatment-with-chemotherapy-associated-or-not-to-erlotini-51658https://curecurrent.com/trials/lower-dose-chemotherapy-given-more-frequent-with-avastin-to-treat-advanced-non-squamous-non-small-cell-lung-cancer-51659https://curecurrent.com/trials/pilot-study-of-safety-and-tolerability-of-nutrifriend-cachexia-in-nsclc-cachexia-51660https://curecurrent.com/trials/bendamustine-with-irinotecan-followed-by-etoposide-carboplatin-for-patients-with-extensive-stage-small-cell-lung-cancer-51661https://curecurrent.com/trials/recombinant-human-endostatin-continued-pumping-into-vein-combining-with-ccrt-in-unresectable-stage-iii-nsclc-51662https://curecurrent.com/trials/luminist-lung-cancer-molecular-insights-non-interventional-study-51663https://curecurrent.com/trials/pemetrexed-disodium-and-cisplatin-in-treating-patients-who-are-undergoing-surgery-for-stage-i-stage-ii-or-stage-iii-non-51664https://curecurrent.com/trials/hypofractionated-radiotherapy-stereotactic-versus-conventional-radiotherapy-for-inoperable-early-stage-i-non-small-cell-51665https://curecurrent.com/trials/enb-and-photodynamic-therapy-in-the-treatment-for-early-lung-cancer-51666https://curecurrent.com/trials/ph-ii-adjuvant-carboplatin-docetaxel-in-curatively-resected-stage-i-iiia-nsclc-51667https://curecurrent.com/trials/a-study-for-subjects-who-are-participating-in-an-astellas-sponsored-asp8273-study-51668https://curecurrent.com/trials/study-of-abraxane-and-carboplatin-to-treat-small-cell-lung-cancer-51669https://curecurrent.com/trials/fob-in-hsct-and-leukemia-patients-with-acute-respiratory-symptoms-and-pulmonary-infiltrates-51670https://curecurrent.com/trials/magnetic-resonance-imaging-mri-in-motion-51671https://curecurrent.com/trials/an-extension-study-of-ro5045337-in-participants-participating-in-previous-roche-sponsored-cancer-studies-51672https://curecurrent.com/trials/combination-vaccine-immunotherapy-dribbles-for-patients-with-definitively-treated-stage-iii-non-small-cell-lung-cancer-51673https://curecurrent.com/trials/neo-masct-immunotherapy-for-advanced-nsclc-51674https://curecurrent.com/trials/hiv-infection-and-tobacco-use-among-injection-drug-users-in-baltimore-maryland-a-pilot-study-of-biomarkers-51675https://curecurrent.com/trials/study-of-tnfr-fc-enbrel-in-the-treatment-of-asthma-51676https://curecurrent.com/trials/a-pilot-open-label-study-of-18f-fluciclatide-pet-ct-imaging-in-the-evaluation-of-anti-angiogenic-therapy-in-solid-tumors-51677https://curecurrent.com/trials/african-american-families-and-lung-cancer-study-51678https://curecurrent.com/trials/evaluation-of-the-association-of-polymorphisms-in-the-innate-immune-system-with-the-risk-for-blastomycosis-dermatitidis-51679https://curecurrent.com/trials/a-phase-i-trial-of-ss1-dsfv-pe38-with-paclitaxel-carboplatin-and-bevacizumab-in-subjects-with-unresectable-non-small-cel-51680https://curecurrent.com/trials/construction-and-use-of-lung-tumor-microarray-for-the-analysis-of-gene-expression-in-lung-cancer-51681https://curecurrent.com/trials/impact-of-lung-cancer-diagnosis-on-relatives-understanding-of-genetic-risk-and-receptivity-to-quit-smoking-51682https://curecurrent.com/trials/pixelshine-vs-iterative-reconstruction-ir-processing-of-ct-images-51683https://curecurrent.com/trials/study-of-tissue-samples-from-patients-with-non-small-cell-lung-cancer-51684https://curecurrent.com/trials/oral-rigosertib-for-squamous-cell-carcinoma-51685https://curecurrent.com/trials/a-long-term-study-to-evaluate-the-safety-and-tolerability-of-cp-690-550-for-patients-with-moderate-to-severe-chronic-pla-51686https://curecurrent.com/trials/immune-response-in-lung-cancer-51687https://curecurrent.com/trials/whole-brain-radiation-therapy-and-pemetrexed-in-treating-patients-with-brain-metastases-from-non-small-cell-lung-cancer-51688https://curecurrent.com/trials/to-predict-efficacy-by-detecting-circulating-endothelial-cell-subsets-and-blood-perfusion-parameters-changes-in-vivo-tum-51689https://curecurrent.com/trials/erlotinib-treatment-beyond-progression-in-egfr-mutant-nsclc-51690https://curecurrent.com/trials/amg-102-and-erlotinib-for-advanced-non-small-cell-lung-cancer-51691https://curecurrent.com/trials/phase-2-study-of-mpdl3280a-combined-with-cdx-1401-in-ny-eso-1-iiib-iv-or-recurrent-non-small-cell-lung-cancer-51692https://curecurrent.com/trials/carboplatin-and-etoposide-plus-lbh589-for-small-cell-lung-cancer-51693https://curecurrent.com/trials/serum-free-fatty-acid-metabolite-biomarkers-of-lung-cancer-51694https://curecurrent.com/trials/combination-chemotherapy-bev-rt-and-erlotinib-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-51695https://curecurrent.com/trials/ldk378-in-adult-patients-with-alk-activated-nsclc-previously-treated-with-chemotherapy-and-crizotinib-51696https://curecurrent.com/trials/a-hospital-based-survey-on-lung-cancer-related-pain-in-northern-china-51697https://curecurrent.com/trials/study-of-pemetrexed-and-gemcitabine-for-patients-with-a-new-diagnosis-of-extensive-stage-small-cell-lung-cancer-51698https://curecurrent.com/trials/audit-of-lung-cancer-screening-practice-in-chest-physicians-an-update-51699https://curecurrent.com/trials/microwave-ablation-in-the-treatment-of-stage-i-non-small-cell-lung-cancer-51700https://curecurrent.com/trials/circulating-cytokines-as-predictors-of-radiation-induced-pulmonary-toxicity-51701https://curecurrent.com/trials/vorinostat-paclitaxel-and-radiation-therapy-in-treating-patients-unable-to-tolerate-cisplatin-with-stage-iii-non-small-l-51702https://curecurrent.com/trials/comparison-of-efficacy-of-paravertebral-and-epidural-analgesia-after-videothoracoscopic-lung-lobectomy-51703https://curecurrent.com/trials/ph-ii-of-vinflunine-and-cetuximab-in-second-line-treatment-of-nsclc-51704https://curecurrent.com/trials/intrapleural-administration-of-hsv1716-to-treat-patients-with-malignant-pleural-mesothelioma-51705https://curecurrent.com/trials/update-of-the-eortc-qlq-lc13-quality-of-life-questionnaire-51706https://curecurrent.com/trials/proteomic-profiling-in-predicting-response-in-patients-receiving-erlotinib-for-stage-iiib-stage-iv-or-recurrent-non-smal-51707https://curecurrent.com/trials/nintedanib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-who-have-failed-up-to-two-previous-chemotherapy-51708https://curecurrent.com/trials/safety-and-tolerability-of-low-dose-temozolomide-during-whole-brain-radiation-in-patients-with-cerebral-metastases-from-51709https://curecurrent.com/trials/phase-2-study-of-temozolomide-in-pre-selected-advanced-aerodigestive-tract-cancers-study-p04273am2-terminated-51710https://curecurrent.com/trials/clinical-validation-of-the-m5l-lung-cad-51711https://curecurrent.com/trials/study-of-maintenance-temozolomide-versus-observation-in-stable-or-responding-stage-iii-iv-non-small-cell-lung-cancer-pat-51712https://curecurrent.com/trials/safety-and-pharmacokinetics-of-escalating-doses-of-dnib0600a-in-participants-with-non-small-cell-lung-cancer-nsclc-and-p-51713https://curecurrent.com/trials/study-on-potential-biomarkers-associated-with-clinical-phenotype-of-egfr-tkis-in-no-small-cell-lung-cancer-in-china-51714https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-budesonide-pt008-in-adult-subjects-with-mild-to-moderate-persistent-asthma-51715https://curecurrent.com/trials/study-evaluating-the-addition-of-fulvestrant-to-erlotinib-in-stage-iiib-iv-non-small-cell-lung-cancer-51716https://curecurrent.com/trials/enb-robotic-icg-guided-surgery-a-novel-technique-for-targeting-small-lung-tumors-51717https://curecurrent.com/trials/video-assisted-intervention-in-improving-recovery-in-patients-with-cancer-undergoing-lung-surgery-and-caregivers-51718https://curecurrent.com/trials/using-fdg-pet-during-radiation-therapy-in-non-small-cell-lung-cancer-51719https://curecurrent.com/trials/observational-study-to-evalute-the-efficacy-and-safety-of-avastin-bevacizumab-in-addition-to-platinum-based-chemotherapy-51720https://curecurrent.com/trials/the-study-of-an-oral-drug-called-a-radiation-sensitizer-in-patients-with-newly-diagnosed-small-cell-lung-cancer-sclc-51721https://curecurrent.com/trials/surgery-with-or-without-internal-radiation-therapy-compared-with-stereotactic-body-radiation-therapy-in-treating-patient-51722https://curecurrent.com/trials/gene-expression-profiling-in-normal-tissue-and-tumor-tissue-from-patients-with-colon-cancer-that-has-spread-to-the-liver-51723https://curecurrent.com/trials/zinc-supplements-in-lowering-cadmium-levels-in-smokers-51724https://curecurrent.com/trials/bupropion-in-helping-adults-stop-smoking-51725https://curecurrent.com/trials/gefitinib-docetaxel-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-51726https://curecurrent.com/trials/a-bioequivalence-study-of-two-oral-formulations-of-topotecan-in-patients-with-advanced-solid-tumors-51727https://curecurrent.com/trials/positron-emission-tomography-and-computed-tomography-in-planning-treatment-for-patients-undergoing-3-dimensional-conform-51728https://curecurrent.com/trials/quality-of-life-in-patients-undergoing-radiation-therapy-for-primary-lung-cancer-head-and-neck-cancer-or-gastrointestina-51729https://curecurrent.com/trials/phase-ii-study-of-cabazitaxel-xrp6258-in-advanced-non-small-cell-lung-cancer-51730https://curecurrent.com/trials/triplet-combination-first-line-treatment-in-non-small-cell-lung-cancer-nsclc-51731https://curecurrent.com/trials/archer-1009-a-study-of-dacomitinib-pf-00299804-vs-erlotinib-in-the-treatment-of-advanced-non-small-cell-lung-cancer-51732https://curecurrent.com/trials/combination-of-sabr-and-l19-il2-in-patients-with-stage-iv-lung-cancer-immunosabr-51733https://curecurrent.com/trials/intestinal-microflora-in-lung-cancer-after-chemotherapy-51734https://curecurrent.com/trials/concurrent-chemo-radiotherapy-with-intensity-modulated-radiation-therapy-imrt-for-limited-disease-small-cell-lung-cancer-51735https://curecurrent.com/trials/concurrent-and-non-concurrent-chemo-radiotherapy-or-radiotherapy-alone-with-intensity-modulated-radiotherapy-imrt-for-no-51736https://curecurrent.com/trials/study-of-temozolomide-in-the-treatment-of-brain-metastasis-from-non-small-cell-lung-cancer-study-p02143-51737https://curecurrent.com/trials/hydroxychloroquine-carboplatin-paclitaxel-and-bevacizumab-in-recurrent-advanced-non-small-cell-lung-cancer-51738https://curecurrent.com/trials/randomized-phase-ii-study-of-azd6244-mitogen-activated-protein-kinase-inhibitor-mek-inhibitor-with-erlotinib-in-kras-wil-51739https://curecurrent.com/trials/circulating-tumor-dna-in-surgical-lung-cancer-patients-51740https://curecurrent.com/trials/biomarker-study-of-blood-samples-from-patients-with-non-small-cell-lung-cancer-treated-with-carboplatin-and-paclitaxel-w-51741https://curecurrent.com/trials/development-of-a-model-to-predict-progression-free-survival-after-erlotinib-in-patients-with-non-small-cell-lung-cancer-51742https://curecurrent.com/trials/a-pilot-trial-of-interpersonal-psychotherapy-for-the-treatment-of-depression-in-patients-with-prostate-colorectal-lung-a-51743https://curecurrent.com/trials/study-of-blood-and-tissue-samples-from-patients-with-locally-advanced-metastatic-or-recurrent-non-small-cell-lung-cancer-51744https://curecurrent.com/trials/preoperative-high-intensity-interval-training-the-phiit-trial-51745https://curecurrent.com/trials/chest-imaging-breath-and-biomarkers-in-a-screening-trial-51746https://curecurrent.com/trials/a-study-of-pro95780-in-patients-with-previously-untreated-advanced-stage-non-small-cell-lung-cancer-apm4074g-51747https://curecurrent.com/trials/biomarkers-predicting-response-in-patients-with-non-small-cell-lung-cancer-previously-treated-with-erlotinib-hydrochlori-51748https://curecurrent.com/trials/bone-metastasis-on-the-survival-of-gefitinib-effective-patients-51749https://curecurrent.com/trials/her-2-mutations-in-tumor-samples-from-patients-with-advanced-non-small-cell-lung-cancer-treated-on-clinical-trial-ecog-2-51750https://curecurrent.com/trials/biomarkers-in-blood-samples-from-patients-with-refractory-non-small-cell-lung-cancer-previously-treated-with-sorafenib-t-51751https://curecurrent.com/trials/study-of-low-dose-chemotherapy-plus-sorafenib-as-initial-therapy-for-patients-with-advanced-non-squamous-cell-nsclc-51752https://curecurrent.com/trials/icotinib-combined-with-sbrt-for-patients-with-metastatic-non-squamous-nsclc-with-egfr-mutation-51753https://curecurrent.com/trials/effect-of-genetic-polymorphisms-on-platinum-based-chemotherapy-in-non-small-cell-lung-cancer-51754https://curecurrent.com/trials/cancer-immunotherapy-gsk1572932a-as-adjuvant-therapy-for-patients-with-tumor-antigen-positive-non-small-cell-lung-cancer-51755https://curecurrent.com/trials/phenethyl-isothiocyanate-in-preventing-lung-cancer-in-smokers-51756https://curecurrent.com/trials/biomarkers-for-diagnosis-of-lung-cancer-51757https://curecurrent.com/trials/cisplatin-and-nab-paclitaxel-for-n2-defined-nsclc-51758https://curecurrent.com/trials/rejuvenair-system-lobectomy-safety-and-histology-study-51759https://curecurrent.com/trials/analgesic-efficacy-of-intravenous-acetaminophen-after-video-assisted-thoracic-surgery-51760https://curecurrent.com/trials/pro-coagulant-markers-and-anticoagulant-failure-in-cancer-patients-at-risk-for-recurrence-of-venous-thromboembolism-51761https://curecurrent.com/trials/rejuvenair-lobectomy-for-safety-and-histology-51762https://curecurrent.com/trials/temozolomide-for-treatment-of-brain-metastases-from-non-small-cell-lung-cancer-study-p03247-51763https://curecurrent.com/trials/a-trial-of-paclitaxel-genexol-and-cisplatin-versus-paclitaxel-loaded-polymeric-micelle-genexol-pm-and-cisplatin-in-advan-51764https://curecurrent.com/trials/positron-emission-tomography-in-predicting-response-in-patients-who-are-undergoing-treatment-with-pemetrexed-disodium-an-51765https://curecurrent.com/trials/evaluation-of-the-high-dose-of-icotinib-in-advanced-lung-cancer-patients-after-failure-of-target-therapy-51766https://curecurrent.com/trials/hypermetabolism-in-the-elderly-lung-cancer-patient-51767https://curecurrent.com/trials/neutropenic-sepsis-in-patients-with-non-small-cell-lung-cancer-treated-with-single-agent-docetaxel-and-associated-resour-51768https://curecurrent.com/trials/erlotinib-and-cetuximab-in-treating-patients-with-advanced-solid-tumors-with-emphasis-on-non-small-cell-lung-cancer-51769https://curecurrent.com/trials/4d-ct-based-ventilation-imaging-for-adaptive-functional-guidance-in-radiotherapy-51770https://curecurrent.com/trials/high-dose-pulsatile-erlotinib-gefitinib-for-advanced-nsclc-patients-after-failure-of-standard-dose-egfr-tkis-51771https://curecurrent.com/trials/seneca-valley-virus-001-after-chemotherapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-51772https://curecurrent.com/trials/the-efficacy-and-safety-of-electronic-cigarettes-a-5-year-follow-up-study-51773https://curecurrent.com/trials/phase-i-study-of-induction-therapy-with-velcade-and-vorinostat-in-patients-with-surgically-resectable-non-small-cell-lun-51774https://curecurrent.com/trials/an-observational-study-of-tarceva-erlotinib-in-participants-with-locally-advanced-or-metastatic-adenocarcinoma-non-small-51775https://curecurrent.com/trials/endobronchial-ultrasound-vs-mediastinoscopy-in-nsclc-51776https://curecurrent.com/trials/ct-perfusion-scans-for-assessment-of-lung-cancer-before-and-after-chemo-radiotherapy-51777https://curecurrent.com/trials/pemetrexed-alimta-plus-cisplatin-followed-by-surgery-and-radiation-therapy-for-mesothelioma-51778https://curecurrent.com/trials/the-added-value-of-quantification-of-lung-function-in-patients-undergoing-radiotherapy-using-tc-99m-maa-spect-ct-51779https://curecurrent.com/trials/losartan-in-treating-pulmonary-fibrosis-in-patients-with-stage-i-ii-or-iii-non-small-cell-lung-cancer-51780https://curecurrent.com/trials/time-of-treatment-with-lmwh-in-cancer-patients-with-thromboembolic-disease-51781https://curecurrent.com/trials/cord-blood-fucosylation-to-enhance-homing-and-engraftment-in-patients-with-hematologic-malignancies-51782https://curecurrent.com/trials/the-efficacy-and-safety-of-apatinib-monotherapy-in-maintenance-treatment-of-extensive-stage-small-cell-lung-cancer-51783https://curecurrent.com/trials/study-of-amiodarone-given-before-lung-surgery-to-prevent-atrial-fibrillation-after-lung-resection-51784https://curecurrent.com/trials/comparison-study-of-sorafenib-and-5-fluorouracil-mitomycin-for-metastatic-hepatocellular-carcinoma-51785https://curecurrent.com/trials/imatinib-mesylate-and-paclitaxel-in-treating-older-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-51786https://curecurrent.com/trials/internet-based-clinical-information-and-blood-sample-collection-from-patients-with-non-small-cell-lung-cancer-who-never-51787https://curecurrent.com/trials/vitamin-supplementation-in-nsclc-patients-on-pemetrexed-based-chemotherapy-51788https://curecurrent.com/trials/safety-and-efficacy-of-carboplatin-paclitaxel-and-carboplatin-paclitaxel-bevacizumab-with-and-without-pictilisib-in-prev-51789https://curecurrent.com/trials/ph-ii-gemcitabine-erlotinib-and-gemcitabine-with-erlotinib-elderly-patients-w-iiib-iv-nsclc-51790https://curecurrent.com/trials/endostar-first-line-treatment-of-advanced-nsclc-51791https://curecurrent.com/trials/phase-3-study-of-bavituximab-plus-docetaxel-versus-docetaxel-alone-in-patients-with-late-stage-non-squamous-non-small-ce-51792https://curecurrent.com/trials/elemene-combine-with-egfr-tki-for-advanced-egfr-tki-resistant-nsclc-51793https://curecurrent.com/trials/identifying-biomarkers-for-lung-cancer-using-tissue-samples-from-patients-with-lung-cancer-and-from-healthy-participants-51794https://curecurrent.com/trials/early-changes-in-positron-emissions-tomography-pet-ct-scan-as-predictors-of-clinical-outcome-in-nsclc-treated-with-egfr-51795https://curecurrent.com/trials/study-of-bavituximab-plus-docetaxel-in-patients-with-locally-advanced-or-metastatic-non-squamous-non-small-cell-lung-can-51796https://curecurrent.com/trials/controls-for-respiratory-diseases-51797https://curecurrent.com/trials/study-of-paclitaxel-carboplatin-with-or-without-bavituximab-in-previously-untreated-non-small-cell-lung-cancer-51798https://curecurrent.com/trials/effect-of-concurrent-chemoradiation-therapy-on-respiratory-muscle-performance-lung-function-and-functional-capacity-in-p-51799https://curecurrent.com/trials/diagnosis-of-lung-cancer-from-exhaled-breath-with-silicon-biophotonic-device-51800https://curecurrent.com/trials/recombinant-endostatin-combined-with-vinorelbine-and-cisplatin-in-patients-with-advanced-non-small-cell-lung-cancer-51801https://curecurrent.com/trials/phase-2a-desipramine-in-small-cell-lung-cancer-and-other-high-grade-neuroendocrine-tumors-51802https://curecurrent.com/trials/caregiver-outlook-an-intervention-to-improve-caregiving-in-serious-illness-51803https://curecurrent.com/trials/de-ct-in-lung-cancer-proton-therapy-51804https://curecurrent.com/trials/dose-range-study-of-anamorelin-in-patients-with-non-small-cell-lung-cancer-51805https://curecurrent.com/trials/the-oncopanel-pilot-top-study-51806https://curecurrent.com/trials/mediastinal-lymph-node-dissection-in-conjunction-with-pulmonary-metastasectomy-from-colorectal-cancer-51807https://curecurrent.com/trials/pulmonary-rehabilitation-in-improving-lung-function-in-patients-with-locally-advanced-non-small-cell-lung-cancer-undergo-51808https://curecurrent.com/trials/a-study-to-assess-biomarkers-impact-on-participants-response-to-erlotinib-treatment-for-first-line-non-small-cell-lung-c-51809https://curecurrent.com/trials/phase-ii-study-of-vs-6063-in-patients-with-kras-mutant-non-small-cell-lung-cancer-51810https://curecurrent.com/trials/acute-and-chronic-pain-especially-neuropathic-pain-after-thoracotomy-and-continuous-application-of-ketamine-51811https://curecurrent.com/trials/neurocognitive-functioning-in-patients-with-newly-diagnosed-upper-aerodigestive-tract-cancer-receiving-treatment-at-henr-51812https://curecurrent.com/trials/68ga-bnota-prgd2-pet-ct-in-healthy-volunteers-and-lung-cancer-patients-51813https://curecurrent.com/trials/mesomir-1-a-phase-i-study-of-targomirs-as-2nd-or-3rd-line-treatment-for-patients-with-recurrent-mpm-and-nsclc-51814https://curecurrent.com/trials/carboplatin-abraxane-and-bevacizumab-in-previously-untreated-patients-with-advanced-non-small-cell-lung-cancer-51815https://curecurrent.com/trials/99mtc-3prgd2-spect-ct-in-lung-cancer-patients-51816https://curecurrent.com/trials/pilot-study-utilizing-manometry-to-assess-radiation-induced-changes-in-esophageal-function-51817https://curecurrent.com/trials/adherence-to-survivorship-care-guidelines-in-health-care-providers-for-non-small-cell-lung-cancer-and-colorectal-cancer-51818https://curecurrent.com/trials/lux-lung-5-afatinib-plus-weekly-paclitaxel-versus-investigator-s-choice-of-single-agent-chemotherapy-following-afatinib-51819https://curecurrent.com/trials/a-study-of-standard-treatment-apatinib-in-extensive-stage-small-cell-lung-cancer-51820https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-cancer-51821https://curecurrent.com/trials/evaluate-the-utility-of-the-prolung-china-test-in-the-diagnosis-of-lung-cancer-51822https://curecurrent.com/trials/systemic-and-topical-treatments-for-rash-secondary-to-erlotinib-in-lung-cancer-51823https://curecurrent.com/trials/a-study-of-metmab-administered-to-patients-with-advanced-non-small-cell-lung-cancer-in-combination-with-tarceva-erlotini-51824https://curecurrent.com/trials/clinical-study-of-ganoderma-lucidum-spore-combined-with-chemotherapy-51825https://curecurrent.com/trials/afatinib-in-patients-with-non-small-cell-lung-cancer-nsclc-with-epidermal-growth-factor-receptor-egfr-mutations-51826https://curecurrent.com/trials/a-study-of-changes-in-fdg-and-flt-pet-imaging-in-patients-with-non-small-cell-lung-cancer-following-treatment-with-erlot-51827https://curecurrent.com/trials/erlotinib-hydrochloride-with-or-without-celecoxib-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-51828https://curecurrent.com/trials/ph-ii-trial-of-carboplatin-and-pemetrexed-with-or-without-azd1775-for-untreated-lung-cancer-51829https://curecurrent.com/trials/cappa-2-cisplatin-added-to-gemcitabine-in-poor-performance-advanced-nsclc-patients-51830https://curecurrent.com/trials/survey-on-the-treatment-reality-of-patients-with-epidermal-growth-factor-receptor-egfr-mutation-positive-non-small-cell-51831https://curecurrent.com/trials/chemotherapy-or-observation-in-treating-patients-with-early-stage-non-small-cell-lung-cancer-51832https://curecurrent.com/trials/circulating-tumor-dna-ctdna-as-a-prognostic-tool-in-patients-with-advanced-lung-adenocarcinoma-51833https://curecurrent.com/trials/preoperative-loading-with-carbohydrates-in-lung-cancer-surgery-51834https://curecurrent.com/trials/pharmacogenomic-phase-ii-study-of-gemcitabine-and-pemetrexed-in-non-small-cell-lung-cancer-51835https://curecurrent.com/trials/induction-gemcitabine-carboplatin-followed-by-paclitaxel-carboplatin-xrt-in-nsclc-51836https://curecurrent.com/trials/the-made-it-clinical-trial-molecular-analyses-directed-individualized-therapy-for-advanced-non-small-cell-lung-cancer-51837https://curecurrent.com/trials/effects-of-nadroparin-in-patients-with-lung-pancreas-or-prostate-cancer-51838https://curecurrent.com/trials/pemetrexed-oxaliplatin-in-patients-w-recurrent-nsclca-after-failure-to-platinum-based-adjuvant-chem-51839https://curecurrent.com/trials/phase-i-ii-trial-of-bevacizumab-pemetrexed-and-erlotinib-in-elderly-patients-with-non-small-cell-lung-cancer-51840https://curecurrent.com/trials/radiomics-a-study-of-outcome-in-lung-cancer-51841https://curecurrent.com/trials/gemcitabine-and-carboplatin-with-or-without-azd2171-as-first-line-therapy-in-treating-patients-with-stage-iiib-or-stage-51842https://curecurrent.com/trials/a-study-of-ginsenoside-h-dripping-pills-for-advanced-non-small-cell-lung-cancer-nsclc-51843https://curecurrent.com/trials/pemetrexed-disodium-with-or-without-sorafenib-as-second-line-therapy-in-treating-patients-with-stage-iiib-or-stage-iv-no-51844https://curecurrent.com/trials/a-phase-iii-trial-of-recombinant-human-apo-2-ligand-for-injection-51845https://curecurrent.com/trials/celecoxib-and-docetaxel-or-pemetrexed-in-treating-patients-with-advanced-recurrent-non-small-cell-lung-cancer-51846https://curecurrent.com/trials/dovitinib-for-patients-with-tumor-pathway-activations-inhibited-by-dovitinib-51847https://curecurrent.com/trials/effects-of-acupuncture-stimulation-on-systemic-inflammation-51848https://curecurrent.com/trials/a-comparison-of-flt-to-fdg-pet-ct-in-the-early-assessment-of-chemotherapy-response-in-stage-ib-iiia-resectable-nsclc-51849https://curecurrent.com/trials/a-study-of-arq-197-in-combination-with-erlotinib-51850https://curecurrent.com/trials/a-study-of-arq-197-in-combination-with-erlotinib-51851https://curecurrent.com/trials/study-to-evaluate-palifermin-in-the-reduction-of-dysphagia-in-patients-with-locally-advanced-non-small-cell-lung-cancer-51852https://curecurrent.com/trials/prognostic-value-of-pd-l1-in-nsclc-51853https://curecurrent.com/trials/phase-2-study-of-neoadjuvant-iressa-treatment-in-stage-1-nsclc-51854https://curecurrent.com/trials/phase-2-dasatinib-combo-with-smoothened-smo-antagonist-bms-833923-51855https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-metmab-combined-with-tarceva-in-patients-with-met-positive-non-small-cell-lung-can-51856https://curecurrent.com/trials/neurocognitive-outcomes-in-patients-treated-with-radiotherapy-for-five-or-more-brain-metastases-51857https://curecurrent.com/trials/computer-generated-quality-of-life-assessment-program-for-advanced-non-small-cell-lung-cancer-patients-lunl2-51858https://curecurrent.com/trials/clinical-trial-evaluating-metronomic-chemotherapy-in-patients-with-metastatic-osteosarcoma-51859https://curecurrent.com/trials/platelet-rich-and-concentrated-platelet-poor-plasma-to-reduce-air-leak-post-lobectomy-a-randomized-controlled-trial-51860https://curecurrent.com/trials/pilot-study-of-regional-lung-ventilation-51861https://curecurrent.com/trials/postoperative-results-of-surgical-treatment-of-lung-cancer-after-30-days-51862https://curecurrent.com/trials/expanded-access-study-of-alectinib-for-participants-with-anaplastic-lymphoma-kinase-alk-rearranged-non-small-cell-lung-c-51863https://curecurrent.com/trials/targeted-treatment-with-intercalated-radiotherapy-in-egfr-mutant-iiia-iiib-nsclc-51864https://curecurrent.com/trials/study-of-safety-efficacy-and-pharmacokinetics-of-ct-707-in-patients-with-alk-positive-non-small-cell-lung-cancer-51865https://curecurrent.com/trials/radiofrequency-ablation-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-51866https://curecurrent.com/trials/veristrat-as-predictor-of-benefit-of-first-line-non-small-cell-lung-cancer-nsclc-patients-from-standard-chemotherapy-51867https://curecurrent.com/trials/pazopanib-in-stage-iiib-iv-nsclc-lung-cancer-after-progression-on-first-line-therapy-containing-bevacizumab-51868https://curecurrent.com/trials/metformin-plus-tki-use-in-patients-with-non-small-cell-lung-carcinoma-51869https://curecurrent.com/trials/radiation-therapy-or-observation-after-chemotherapy-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer-51870https://curecurrent.com/trials/prophylactic-cranial-irradiation-pci-versus-no-pci-in-non-small-cell-lung-cancer-after-a-response-to-chemotherapy-51871https://curecurrent.com/trials/phase-2-trial-of-bevacizumab-in-combination-with-pemetrexed-51872https://curecurrent.com/trials/alk-rearrangements-in-lung-adenocarcinoma-epidemiology-in-latin-america-clicap-51873https://curecurrent.com/trials/tailored-post-surgical-therapy-in-early-stage-nsclc-51874https://curecurrent.com/trials/clinical-trial-on-the-prevention-of-thrombocytopenia-after-first-line-chemotherapy-51875https://curecurrent.com/trials/study-of-panobinostat-in-combination-with-sorafenib-in-kidney-soft-tissue-or-lung-cancers-51876https://curecurrent.com/trials/chemotherapy-and-erlotinib-for-lung-cancer-with-low-abundance-epidermal-growth-factor-receptor-mutation-51877https://curecurrent.com/trials/a-french-survey-of-the-diagnostic-and-therapeutic-management-of-elderly-people-with-histologically-cytologically-confirm-51878https://curecurrent.com/trials/predictors-of-radiation-pneumonitis-in-locally-advanced-lung-cancer-treated-with-chemoradiation-51879https://curecurrent.com/trials/phase-ii-study-of-docetaxel-zd1839-in-elderly-patients-with-non-small-cell-lung-cancer-51880https://curecurrent.com/trials/nedaplatin-jiebaishu-combined-with-docetaxel-for-advanced-lung-squamous-cell-carcinoma-51881https://curecurrent.com/trials/seretide-100-50-bd-twice-daily-versus-flixotide-100-bd-as-initial-maintenance-therapy-in-moderate-asthma-in-adults-51882https://curecurrent.com/trials/efficacy-safety-of-imprime-pgg-injection-with-bevacizumab-and-paclitaxel-carboplatin-in-patients-with-untreated-advanced-51883https://curecurrent.com/trials/topotecan-plus-cisplatin-versus-etoposide-plus-cisplatin-in-1st-line-extensive-disease-small-cell-lung-cancer-51884https://curecurrent.com/trials/icotinib-or-whole-brain-irradiation-in-egfr-mutant-lung-cancer-51885https://curecurrent.com/trials/phase-iii-trial-to-evaluate-the-elortinib-vs-gefitinib-in-advanced-nsclc-with-egfr-exon-19-or-21-mutations-51886https://curecurrent.com/trials/a-prospective-epidemiologic-study-of-alk-positive-nsclc-in-china-51887https://curecurrent.com/trials/study-of-blood-tumor-and-adjacent-normal-tissue-samples-from-chinese-smoking-induced-lung-cancer-patients-51888https://curecurrent.com/trials/a-study-of-oral-gw572016-in-advanced-or-metastatic-non-small-cell-lung-cancer-51889https://curecurrent.com/trials/anti-cancer-muc1-specific-immunotherapy-for-unresectable-stage-iii-non-small-cell-lung-cancer-51890https://curecurrent.com/trials/standard-chemotherapy-with-of-without-axitinib-in-malignant-mesothelioma-51891https://curecurrent.com/trials/chemotherapy-plus-bevacizumab-in-elderly-non-small-cell-lung-cancer-patients-51892https://curecurrent.com/trials/preoperative-pemetrexed-and-carboplatin-for-select-stage-ib-ii-and-iii-non-squamous-non-small-cell-lung-cancer-51893https://curecurrent.com/trials/registry-study-on-biological-disease-profile-and-clinical-outcome-in-patients-with-newly-diagnosed-or-existent-lung-canc-51894https://curecurrent.com/trials/blood-detection-of-egfr-mutation-for-iressa-treatment-51895https://curecurrent.com/trials/study-of-apatinib-as-3rd-4th-line-treatment-in-patients-with-advanced-non-squamous-non-small-cell-lung-cancer-harboring-51896https://curecurrent.com/trials/zeushield-cytotoxic-t-lymphocytes-z-ctls-for-relapsed-or-refractory-non-small-cell-lung-cancer-nsclc-51897https://curecurrent.com/trials/phase-i-dasatinib-erlotinib-in-recurrent-non-small-cell-lung-cancer-nsclc-51898https://curecurrent.com/trials/use-of-18-f-fdg-on-pet-ct-as-an-alternative-non-invasive-method-for-staging-of-lung-cancer-51899https://curecurrent.com/trials/the-treatment-of-advanced-lung-cancer-with-dribbles-antigen-by-targeting-activation-of-tcells-51900https://curecurrent.com/trials/efficacy-and-safety-of-rad001-in-patients-aged-18-and-over-with-angiomyolipoma-associated-with-either-tuberous-sclerosis-51901https://curecurrent.com/trials/apatinib-mesylate-combined-with-pemetrexed-in-the-treatment-of-pretreated-advanced-non-squamous-non-small-cell-lung-canc-51902https://curecurrent.com/trials/mutation-detection-of-ebus-tbna-specimens-using-ngs-51903https://curecurrent.com/trials/prognostic-study-of-metastases-in-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-cancer-that-can-be-rem-51904https://curecurrent.com/trials/risk-factors-associated-to-difficult-to-control-asthma-51905https://curecurrent.com/trials/clinical-application-of-mr-pet-in-non-small-cell-lung-cancer-diagnosis-treatment-outcome-and-prognosis-prediction-51906https://curecurrent.com/trials/adjuvant-pembrolizumab-in-n2-positive-non-small-cell-lung-cancer-patients-51907https://curecurrent.com/trials/study-of-ibrutinib-followed-by-ibrutinib-in-combination-with-nivolumab-in-non-small-cell-lung-cancer-nsclc-51908https://curecurrent.com/trials/single-agent-alimta-in-poor-performance-status-in-non-small-cell-lung-cancer-51909https://curecurrent.com/trials/a-study-comparing-pemetrexed-plus-cisplatin-versus-pemetrexed-alone-in-nsclc-patients-who-have-progressed-on-first-line-51910https://curecurrent.com/trials/apatinib-combine-with-egfr-tki-for-advanced-egfr-tki-resistant-non-small-cell-lung-cancer-51911https://curecurrent.com/trials/fdg-labeled-pet-scan-in-planning-chemotherapy-in-treating-patients-with-stage-iiib-or-iv-non-small-cell-lung-cancer-51912https://curecurrent.com/trials/a-study-of-cetuximab-combined-with-cisplatin-or-carboplatin-pemetrexed-as-first-line-treatment-in-patients-with-malignan-51913https://curecurrent.com/trials/study-of-dc-ctl-combined-with-cik-for-advanced-solid-tumor-51914https://curecurrent.com/trials/icotinib-as-first-line-and-maintenance-treatment-in-egfr-mutated-patients-with-lung-adenocarcinoma-51915https://curecurrent.com/trials/acceptability-of-less-harmful-alternatives-to-cigarettes-51916https://curecurrent.com/trials/phase-ii-study-of-erlotinib-with-concurrent-radiotherapy-in-unresectable-nsclc-with-activating-mutation-of-egfr-in-exon-51917https://curecurrent.com/trials/icotinib-at-different-doses-in-second-line-treatment-for-non-small-cell-lung-cancer-patients-with-wild-type-egfr-51918https://curecurrent.com/trials/temsirolimus-in-treating-patients-with-metastatic-neuroendocrine-carcinoma-51919https://curecurrent.com/trials/ebus-tbna-vs-flex-19g-ebus-tbna-51920https://curecurrent.com/trials/combined-effect-of-natural-killer-cell-and-doublet-chemotherapy-in-advanced-nsclc-as-the-1st-line-treatment-51921https://curecurrent.com/trials/lume-lung-2-bibf-1120-plus-pemetrexed-compared-to-placebo-plus-pemetrexed-in-2nd-line-nonsquamous-nsclc-51922https://curecurrent.com/trials/thohspekt-thoracoscopic-ectomy-of-radioactively-marked-pulmonary-nodules-with-free-hand-spect-51923https://curecurrent.com/trials/feasibility-study-of-sbrt-plus-chemotherapy-for-non-small-cell-lung-carcinoma-51924https://curecurrent.com/trials/prevention-of-radiation-pneumonitis-after-three-dimensional-conformal-radiation-therapy-3d-crt-in-patients-with-non-smal-51925https://curecurrent.com/trials/study-of-cetuximab-with-radiation-followed-by-consolidation-chemotherapy-for-nsclc-51926https://curecurrent.com/trials/supportive-care-for-patients-newly-diagnosed-with-lung-cancer-51927https://curecurrent.com/trials/a-study-of-intermittent-high-dose-afatinib-to-determine-the-maximal-tolerated-dose-and-assess-activity-of-this-dose-agai-51928https://curecurrent.com/trials/stereotactic-radiosurgery-and-systemic-dose-chemotherapy-for-locally-advanced-lung-cancer-51929https://curecurrent.com/trials/placebo-controlled-study-of-vs-6063-in-subjects-with-malignant-pleural-mesothelioma-51930https://curecurrent.com/trials/hydroxychloroquine-with-or-without-erlotinib-in-advanced-non-small-cell-lung-cancer-nsclc-51931https://curecurrent.com/trials/a-phase-1-dose-escalation-study-of-vs-5584-administered-in-combination-with-vs-6063-in-subjects-with-relapsed-malignant-51932https://curecurrent.com/trials/cesium-131-seed-brachytherapy-plus-subtotal-resection-for-lung-cancer-patients-51933https://curecurrent.com/trials/evaluation-of-the-archimedes-system-for-transparenchymal-nodule-access-51934https://curecurrent.com/trials/intercalating-and-maintenance-use-of-iressa-versus-chemotherapy-in-selected-advanced-non-small-cell-lung-cancer-51935https://curecurrent.com/trials/pemetrexed-carboplatin-and-bevacizumab-as-first-line-therapy-in-treating-older-patients-with-stage-iiib-or-stage-iv-non-51936https://curecurrent.com/trials/a-study-evaluating-ro5479599-in-combination-with-carboplatin-and-paclitaxel-in-participants-with-advanced-or-metastatic-51937https://curecurrent.com/trials/detection-of-csf-next-generation-sequencing-in-the-application-of-brain-metastases-from-lung-adenocarcinoma-or-meningeal-51938https://curecurrent.com/trials/a-trial-to-evaluate-the-improvement-in-lung-cancer-patients-receiving-radiation-with-or-without-brachytherapy-51939https://curecurrent.com/trials/pd-l1-and-other-immuno-markers-influenced-by-osimertinib-treatment-in-advanced-nsclc-patients-51940https://curecurrent.com/trials/assessing-the-link-between-smoke-carcinogen-biomarkers-and-lung-cancer-risk-1-51941https://curecurrent.com/trials/extrapleural-pneumonectomy-pleurectomy-decortication-ihoc-cisplatin-and-gemcitabine-with-amifostine-and-sodium-thiosulfa-51942https://curecurrent.com/trials/egfr-tki-resistance-profile-in-chinese-patients-with-advanced-egfrm-nsclc-51943https://curecurrent.com/trials/high-dose-ice-with-amifostine-51944https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-cancer-51945https://curecurrent.com/trials/therapeutic-resistance-prediction-of-tyrosine-kinase-inhibitors-51946https://curecurrent.com/trials/gemcitabine-and-docetaxel-in-treating-patients-with-recurrent-stage-iii-or-stage-iv-non-small-cell-lung-cancer-51947https://curecurrent.com/trials/cohort-study-to-identify-cancer-patients-at-high-risk-of-venous-thromboembolism-51948https://curecurrent.com/trials/cilengitide-and-cetuximab-in-combination-with-platinum-based-chemotherapy-as-first-line-treatment-for-subjects-with-adva-51949https://curecurrent.com/trials/an-investigational-drug-pf-02341066-is-being-studied-in-patients-with-advanced-non-small-cell-lung-cancer-with-a-specifi-51950https://curecurrent.com/trials/conformal-radiation-therapy-in-treating-patients-with-metastatic-cancer-outside-the-brain-51951https://curecurrent.com/trials/results-from-a-health-system-wide-implementation-of-a-quality-of-life-questionnaire-51952https://curecurrent.com/trials/bio-behavioral-lung-cancer-prevention-program-51953https://curecurrent.com/trials/circulating-tumor-cells-ctcs-as-a-blood-based-tumor-marker-in-patients-with-small-cell-lung-cancer-sclc-51954https://curecurrent.com/trials/assessing-the-variability-over-time-of-tobacco-carcinogen-biomarkers-in-smokers-2-51955https://curecurrent.com/trials/comparison-of-gene-mutations-in-matched-samples-in-advanced-nonsquamous-nsclc-using-ngs-51956https://curecurrent.com/trials/feasibility-of-a-8-week-telerehabilitation-program-for-patients-with-thoracic-neoplasia-receiving-chemotherapy-51957https://curecurrent.com/trials/enb-guided-rfa-for-early-stage-peripheral-lung-cancer-51958https://curecurrent.com/trials/body-composition-analysis-for-patient-with-lung-cancer-using-computed-tomography-image-analysis-51959https://curecurrent.com/trials/characterization-of-peripheral-muscle-function-in-patients-with-non-small-cell-lung-cancer-51960https://curecurrent.com/trials/phase-iib-iii-of-tg4010-immunotherapy-in-patients-with-stage-iv-non-small-cell-lung-cancer-51961https://curecurrent.com/trials/endostar-plus-egfr-tki-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor-as-a-treatment-of-egfr-mutation-positi-51962https://curecurrent.com/trials/an-investigational-drug-pf-02341066-is-being-studied-versus-standard-of-care-in-patients-with-advanced-non-small-cell-lu-51963https://curecurrent.com/trials/efficacy-safety-tolerability-of-gefitinib-as-1st-line-in-caucasian-patients-with-egfr-mutation-positive-advanced-nsclc-51964https://curecurrent.com/trials/clinical-study-of-yq1-plus-cisplatin-based-chemotherapy-in-advanced-nsclc-egfr-wild-type-51965https://curecurrent.com/trials/adjuvant-erlotinib-intercalating-chemotherapy-or-adjuvant-chemotherapy-alone-in-nsclc-with-common-egfr-mutation-51966https://curecurrent.com/trials/low-dose-chest-computed-tomography-ct-screening-51967https://curecurrent.com/trials/sorafenib-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-51968https://curecurrent.com/trials/egfr-tki-with-without-chemotherapy-in-nsclc-patients-with-both-egfr-mutation-and-bim-deletion-polymorphism-51969https://curecurrent.com/trials/trial-of-rad001-in-patients-with-operable-non-small-cell-lung-cancer-nsclc-51970https://curecurrent.com/trials/complete-endosonographic-intrathoracic-nodal-staging-of-lung-cancer-patients-in-whom-sabr-is-considered-51971https://curecurrent.com/trials/video-assisted-thoracoscopic-surgery-teams-perception-of-non-technical-skills-51972https://curecurrent.com/trials/to-predict-efficacy-by-detecting-circulating-endothelial-cell-subsets-and-blood-perfusion-parameters-changes-in-vivo-tum-51973https://curecurrent.com/trials/diffusion-weighted-mri-for-individualized-radiation-therapy-planning-of-lung-cancer-51974https://curecurrent.com/trials/trial-of-abi-007-administered-weekly-in-chemotherapy-naive-patients-with-advanced-non-small-cell-lung-cancer-51975https://curecurrent.com/trials/gemcitabine-and-oxaliplatin-as-second-line-therapy-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-c-51976https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-stage-iii-stage-iv-or-relapsed-non-small-cell-lung-cancer-treated-with-first-l-51977https://curecurrent.com/trials/the-copenhagen-city-heart-study-51978https://curecurrent.com/trials/revlimid-as-consolidation-treatment-chronic-lymphocytic-leukemia-51979https://curecurrent.com/trials/carboplatin-irinotecan-and-radiation-therapy-followed-by-docetaxel-in-treating-patients-with-newly-diagnosed-stage-iii-n-51980https://curecurrent.com/trials/gefitinib-with-or-without-carboplatin-and-paclitaxel-in-treating-older-patients-with-unresectable-or-metastatic-non-smal-51981https://curecurrent.com/trials/single-port-two-port-versus-three-port-vats-on-non-small-cell-lung-cancer-51982https://curecurrent.com/trials/correlation-between-egfr-mutation-using-cfdnas-and-circulating-tumor-cells-in-patients-with-nsclc-51983https://curecurrent.com/trials/temsirolimus-and-pemetrexed-for-recurrent-or-refractory-non-small-cell-lung-cancer-51984https://curecurrent.com/trials/a-phase-ii-study-of-radiation-therapy-paclitaxel-poliglumex-and-carboplatin-in-stage-iii-non-small-cell-lung-cancer-51985https://curecurrent.com/trials/outpatient-chest-tube-management-following-thoracic-resection-improves-patient-length-of-stay-and-satisfaction-without-c-51986https://curecurrent.com/trials/dalteparin-for-primary-venous-thromboembolism-vte-prophylaxis-in-pancreatic-cancer-patients-51987https://curecurrent.com/trials/early-palliative-care-on-quality-of-life-of-advanced-cancer-patients-51988https://curecurrent.com/trials/combination-chemotherapy-and-exisulind-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-51989https://curecurrent.com/trials/gemcitabine-and-epirubicin-in-treating-patients-with-malignant-mesothelioma-51990https://curecurrent.com/trials/docetaxel-with-or-without-infliximab-in-treating-weight-loss-loss-of-appetite-and-fatigue-in-patients-with-unresectable-51991https://curecurrent.com/trials/combination-chemotherapy-with-or-without-filgrastim-in-treating-patients-with-previously-untreated-extensive-stage-small-51992https://curecurrent.com/trials/a-phase-3-randomized-double-blinded-placebo-controlled-study-of-arq-197-plus-erlotinib-versus-placebo-plus-erlotinib-51993https://curecurrent.com/trials/concurrent-pemetrexed-cisplatin-with-pleural-intensity-modulated-radiation-therapy-for-patients-with-unresectable-malign-51994https://curecurrent.com/trials/pemetrexed-disodium-plus-gemcitabine-in-treating-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-51995https://curecurrent.com/trials/dynamic-circulating-tumor-cell-ctc-changes-during-the-chemotherapy-in-nsclc-51996https://curecurrent.com/trials/irinotecan-plus-cisplatin-compared-with-etoposide-plus-cisplatin-for-extensive-stage-small-cell-lung-cancer-51997https://curecurrent.com/trials/phase-i-study-of-vorinostat-in-combination-with-docetaxel-in-patients-with-advanced-and-relapsed-solid-malignancies-51998https://curecurrent.com/trials/topotecan-plus-apatinib-versus-topotecan-alone-as-second-line-therapy-in-small-cell-lung-cancer-51999https://curecurrent.com/trials/combination-chemotherapy-plus-radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-52000